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5Abstract
The rupture of a cerebral artery aneurysm causes a devastating
subarachnoid hemorrhage (SAH), with a mortality of almost 50% during the first
month.  Each year, 8-11/100 000 people suffer from aneurysmal SAH in Western
countries, but the number is twice as high in Finland and Japan.  The disease is most
common among those of working age, the mean age at rupture being 50-55 years.
Unruptured cerebral aneurysms are found in 2-6% of the population, but knowledge
about the true risk of rupture is limited.  The vast majority of aneurysms should be
considered rupture-prone, and treatment for these patients is warranted.
Both unruptured and ruptured aneurysms can be treated by either
microsurgical clipping or endovascular embolization.  In a standard microsurgical
procedure, the neck of the aneurysm is closed by a metal clip, sealing off the
aneurysm from the circulation.  Endovascular embolization is performed by packing
the aneurysm from the inside of the vessel lumen with detachable platinum coils.
Coiling is associated with slightly lower morbidity and mortality than microsurgery, but
the long-term results of microsurgically treated aneurysms are better.
Endovascular treatment methods are constantly being developed further in
order to achieve better long-term results.  New coils and novel embolic agents need
to be tested in a variety of animal models before they can be used in humans.  In this
study, we developed an experimental rat aneurysm model and showed its suitability
for testing endovascular devices.  We optimized noninvasive MRI sequences at 4.7
Tesla for follow-up of coiled experimental aneurysms and for volumetric
measurement of aneurysm neck remnants.  This model was used to compare
platinum coils with polyglycolic-polylactic acid (PGLA) -coated coils, and showed the
benefits of the latter in this model.  The experimental aneurysm model and the
imaging methods also gave insight into the mechanisms involved in aneurysm
formation, and the model can be used in the development of novel imaging
techniques.  This model is affordable, easily reproducible, reliable, and suitable for
MRI follow-up.  It is also suitable for endovascular treatment, and it evades
spontaneous occlusion.
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91.  Introduction
The rupture of a cerebral artery aneurysm causes a devastating
subarachnoid hemorrhage (SAH). The 1-month mortality is almost 50% (Sarti et al.
1991), and 24% of patients are left with permanent neurological deficits (Hernesniemi
et al. 1993, Hop et al. 1997).  The incidence of aneurysmal SAH is 8-11/100 000 in
Western countries (Phillips et al. 1980, Ingall et al. 1989, van Gijn et al. 2007, de
Rooij et al. 2007, Bederson et al. 2009), but this number is twice as high in Finland
and Japan (Sarti et al. 1991, Ohkuma et al. 2002).  This disease is most common
among those of working age, the mean age at rupture being 50-55 years (Mahindu et
al. 2008, van Munster et al 2008).  Unruptured cerebral aneurysms are found in 2-6%
of the population (Ronkainen et al. 1998, Rinkel et al. 1998), but why only some of
them rupture remains unknown.  Risk factors associated with aneurysm growth and
rupture have been identified: smoking, hypertension, excessive alcohol use, female
gender, family history, aneurysm size, and aneurysm site (Hillbom et al. 1981, Bonita
1986, Juvela et al. 2000, Juvela et al. 2001, Wiebers et al. 2003, de Rooij et al. 2007,
Ishibashi 2009, Woo et al. 2009).  However, no reliable methods exist for estimating
the natural progression of an aneurysm (Koffijberg et al. 2008), and thus far it is not
possible to predict which aneurysms will rupture.  Therefore, all aneurysms must be
considered potentially lethal, and patients should be evaluated for their suitability for
treatment.  The risk of rupture must always be weighted against the age- and
comorbidity-adjusted risks associated with treatment.
Both unruptured and ruptured aneurysms can be treated by either
microsurgical clipping or endovascular embolization.  Endovascular embolization is
performed by packing the aneurysm with detachable platinum coils, nowadays often
together with balloon remodeling or with stents.  Coiling is preferred in many
neurosurgical centers since it has been shown to be associated with a slightly lower
morbidity, especially in the posterior circulation, than surgery (Koivisto et al. 2000,
Molyneux et al. 2002, Taha et al. 2006).  However, the initial angiographic results of
coiled aneurysm disturbingly often show incomplete occlusion, with persisting neck
remnants or filling of the fundus of the aneurysm (Vanninen et al. 1999, Molyneux et
al. 2002, Raymond et al. 2003, Taha et al. 2006).  In addition, even perfectly coiled
aneurysms may undergo coil compaction and recanalization, leading to an increased
risk of rupture (Raymond et al. 2003), necessitating  angiographic follow-up and
eventual re-treatment (Vanninen et al. 1999, Raymond et al. 2003).  Although studies
with selected patients show good long-term results after coiling, other studies show
significantly poorer results depending on aneurysm morphology, size, and location.
The clinician is forced to balance the risks and benefits of surgical clipping, which
offers a very small risk of recurrence when performed properly (Tsutsumi et al. 2001),
with the long-term uncertainties and mandatory long-term follow-up associated with
the less invasive coiling.  The immediate (24 h) risks of coiling also cannot be
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dismissed, as 3.8% patients may suffer from an thromboembolic event or transient
ischemic attacks (Derdeyn et.al. 2002).  Moreover, according to a meta-analysis by
Brilstra et al. (1999), the intraprocedural rupture incidence is 4.5%.  Periprocedural
complications are seen in 8.4% of endovascularly treated patients and in 19.4% of
surgically treated patients (Taha et al 2006).  Therefore, development of even safer
and especially more efficient endovascular treatment methods is needed.
Today, coiling is dependent on the mechanical occlusion of the aneurysm,
and the results are better when higher packing density is achieved.  In order to fill the
aneurysm as densely as possible, balloon-assisted remodeling techniques and
stenting methods have been developed.  However, this makes the procedure even
more demanding and time-consuming, theoretically increasing the complication rate.
Efforts should be directed towards creating simpler endovascular techniques and the
ongoing development should emphasize on the biological effect of the coil, made
possible by the increasing knowledge on aneurysm pathobiology (Peters et al. 1999,
2001, Frösen et al. 2004, Tulamo et al. 2006, Laaksamo et al. 2008).  Coils could be
coated with biologically active agents, like growth factors, to induce myointimal
hyperplasia and strengthen the aneurysm wall.  Hopefully, in the future, biologically
active coils will work as a form of local drug delivery into the aneurysm, and their
effect will not depend on the packing density, but rather on other properties that will
stabilize the aneurysm and progressively occlude it.  In this way, aneurysms that
depending on their location or local anatomy (e.g. branches arising near the
aneurysm), are difficult to treat endovascularly and even more so microsurgically,
would be applicable for therapy with a more simple coil.  These futuristic tools would
enable us to treat aneurysms at difficult sites and with complex angioarchitecture
better.
When new endovascular devices are developed, they need to be tested in
experimental animal models before being used in humans.  A good experimental
animal model must be easy to reproduce and reliable, and it also has to evade
spontaneous occlusion.  Repeated in vivo radiological follow-up examinations of the
experimental aneurysm are required, and the chosen imaging technique should have
a resolution that enables detection of even small changes at the interface between
the aneurysm neck and the coil surface.  At the end of the study, animals should be
sacrificed and the samples analyzed by histological methods.
Experimental aneurysm models suitable for endovascular treatment have
been developed in swine, rabbits, and dogs. In the swine model, a jugular vein graft
is used to construct an aneurysm in the carotid artery (Guglielmi et al. 1994).  In the
rabbit model, elastase-induced aneurysms are formed in ligated stumps of the carotid
arteries (Cawley et al. 1996).  The follow-up has been performed by digital
subtraction angiography (DSA).  In order to test the efficacy of the devices, it is
important that the untreated aneurysm remains patent or grows.
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In this study, we developed a surgically created aneurysm model in rats and mice.
The rat model is suitable for endovascular treatment since the experimental
aneurysms resemble the smallest ruptured aneurysms in humans.  The model is
easy to standardize and highly reproducible.  Because of the low mortality rate and
the inexpensive price of the animals, our model is also more affordable than the other
experimental aneurysm models.  The mouse model allows the use of widely available
transgenic strains in order to dissect mechanisms involved in the pathobiology of
aneurysm formation.  However, the main reason for choosing to use rats and mice
was that noninvasive follow-up with a 4.7 Tesla magnetic resonance (MR) scanner
was possible only with animals small enough to fit into the bore of the scanner.  For
magnetic resonance imaging (MRI), we optimized an imaging protocol including a
high-resolution (117 x 117 x 117 µm) time-of-flight magnetic resonance angiography
(TOF-MRA) sequence for volumetric measurement of  aneurysm neck remnants.
Using the rat model and the optimized MR imaging protocol we performed a study
comparing the effects of platinum coils with polyglycolic-polylactic acid (PGLA) -
coated coils.  With MRI, we were able to detect even small changes in the aneurysm
neck during follow-up.  We also investigated the suitability of a genetically modified
mouse strain (Col-Int?) for the study of aneurysm formation by optimizing an MR
imaging protocol for the mouse aorta and cerebral arteries and scanning these
vessels for aneurysms.  Murines are the most commonly used animals at our
research facility (Biomedicum, Helsinki).
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2.  Review of the literature
2.1  Cerebral artery aneurysms
2.1.1  Prevalence and etiology
The estimated prevalence of unruptured cerebral artery aneurysms in the
general population varies between 0.8%  and 8.1% (Byrne et. Guglielmi 1998, Rinkel
et al. 1998, Ronkainen et al. 1998).  According to a meta-analysis of autopsy and
angiographic studies, the incidence of cerebral aneurysms in an adult population
without risk factors for SAH is 2%, most aneurysms being less than 10 mm in
diameter (Rinkel et al. 1998).  In a Finnish forensic autopsy study, the prevalence
was 2.2% for aneurysms ?3 mm (Ronkainen et al. 1998).  Based on their
morphology, aneurysms can be classified into the more common (98%) saccular or
the rare fusiform (Ya?argil 1984) and dissecting types.  Saccular aneurysms are most
often berry-like protrusions that have a well-defined  neck (often narrow), sometimes
with a multilobular appearance or a wide neck.  The largest diameter of a ruptured
saccular cerebral artery aneurysm (SCAA) is on average 11 mm, whereas incidental
aneurysms are on average only 6 mm (Juvela et al. 2001).  Aneurysms larger than
25 mm in diameter (giant aneurysms) comprise 3-5% of all aneurysms (McCormick et
al. 1970, Choi et al. 2003).  Up to one-third of patients have multiple aneurysms
(Rinne et al. 1994).  Most of the saccular aneurysms (85-95%) are located in the
anterior circulation (carotid system) and only 5-15% in the posterior circulation
(vertebro-basilar system).  Aneurysms usually arise in the bifurcations of proximally
located cerebral arteries, of these the most frequent sites are the Acom (30%), Pcom
(25%) and MCA (20%) (Weir et. MacDonald 1996).  In Finland MCA aneurysms are
predominant (Pakarinen 1967, Fogelholm 1981, Rinne  et  al.  1996).   The
hemodynamic stress in these locations most probably favors aneurysm formation, but
this is not the only explanation.  The true etiology appears to be much more complex
and is incompletely known.  On histological inspection, the cerebral arteries lack an
external elastic lamina (between the media and adventitia layer) and have gaps in
the media layer at bifurcations where muscle is replaced by connective tissue
(Wilkinson 1972, Finlay et al. 1998).  Moreover, inflammation (Frösen et al. 2004,
Tulamo et al. 2006), lipid deposition and the formation of such atherosclerotic
changes as myointimal hyperplasia may be important contributing factors.  A minority
of aneurysms have a traumatic (Benoit et al. 1973) or infectious etiology (Frazee et
al. 1980, Clare et al. 1992, Kumar et al. 1998).
Patients with certain relatively rare inherited diseases such as polycystic
kidney disease (PKD) (Butler et al. 1996, Belz et al. 2001), fibromuscular dysplasia
(FMD) and diseases that affect the connective tissue e.g. Ehlers Danlos type IV and
Marfan´s syndrome (ter Berg et al. 1986), have higher risk of developing aneurysms.
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2.1.2  Cerebral artery aneurysm rupture
The natural history of cerebral artery aneurysms is not fully known.  Thus
far, it is not possible to predict which aneurysms will rupture and when.  The
multinational ISUIA (International Study of Unruptured Intracranial Aneurysms), the
largest study on this subject, concluded that the risk of rupture is dependent on
aneurysm location, size, and previous history of SAH (Wiebers et al. 2003).
According to ISUIA, the risk of rupture of aneurysms less than 7 mm in diameter is
only about 0.1% per year if no previous history of SAH exists the risk being higher in
posterior than anterior circulation.  On the other hand, for example for Pcom
aneurysms larger than 25 mm the 5-year cumulative risk of rupture is 50%.  The
ISUIA results for small aneurysms differ from other studies.  Juvela et al. (2000)
reported an overall annual risk of rupture of 1.3% in Finland.  This risk accumulates
over time, being 10.5% at 10 years and 30.3% at 30 years (Juvela et.al. 2000) and
also aneurysms ? 6 mm in diameter have a 1.1% risk of rupture.  However, most
patients in their study had a history of previous SAH, which makes it difficult to
directly compare these results with ISUIA.  In addition to aneurysm size and location,
also gender, age, cigarette smoking, hypertension, and alcohol consumption are
important risk factors predisposing to rupture (Hillbom et al. 1981, Bonita 1986,
Juvela et al. 2000, Juvela et al. 2001, Wiebers et al. 2003, de Rooij et al. 2007,
Ishibashi et al. 2009, Woo et al. 2009).  Diabetes and hypercholesterolemia, in turn,
have not been shown to increase the risk.
Aneurysm rupture most commonly results in a SAH.  An intracerebral
hematoma with or without SAH is seen in 20-40% of patients, whereas
intraventricular hemorrhage occurs in 13-28% (Yeh et al. 1985) and subdural
hemorrhage in 2% (Gelabert-Gonzalez et al. 2004).
2.1.2.1  Subarachnoid hemorrhage
Rupture of cerebral artery aneurysms accounts for approximately 80%
(Kassell et al 1990a, van Gijn et al 2001) of all nontraumatic cases of SAH, the rest
being from e.g. cerebral arteriovenous malformations (AVMs) or unknown causes
(Ronkainen et. Hernesniemi 1992).  The annual incidence of aneurysmal SAH is 8-
11/100 000 in Western countries (Phillips et al. 1980, Ingall et al. 1989, de Rooij et al.
2007, van Gijn et al. 2007, Bederson et al. 2009).  In Finland, the risk is more than
twice as high, being 25/100 000 among Finnish women and 33/100 000 among
Finnish men (Sarti et al 1991).  The risk is also higher in the Japanese population,
being 21/100 000 (Ohkuma et al. 2002).  Most patients are 50-55 years of age
(Mahindu et al. 2008, van Munster et al 2008), but the proportion of older and more
fragile patients is increasing.  The outcome of SAH is still devastating, with a 1-month
mortality rate of 46% in women and 48% in men (Sarti et al. 1991).  Moreover,
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approximately 24% of the survivors are left with moderate to severe disability
(Hernesniemi et al. 1993).  The case-fatality rate has, however, decreased during the
last decades due to improved management (Hop et al. 1997), including ultra early
treatment, antifibrinolytic therapy, neurointensive care and monitoring, and
vasospasm prevention and treatment.
Acute SAH is a complex and critical condition requiring a dedicated
multidisciplinary neurocare team.  The clinical presentation of SAH is an acute,
severe headache, which can be accompanied by a variety of symptoms such as
nausea, vomiting, drowsiness, loss of consciousness, and meningismus.  In the case
of an intracerebral hematoma, hemiparesis and symptoms of herniation may occur.
A significant number of patients (30-60%) suffer from a warning leak and symptoms
that pass within a day, some days before the major bleeding.  SAH is reliably
diagnosed with a computed tomography (CT) scan or lumbar puncture (van Gijn et al.
1980, van der Wee et al 1995).  The source of bleeding must be identified, and this is
usually done by computed tomography angiography (CTA) or digital subtraction
angiography (DSA) and sometimes magnetic resonance angiography (MRA) since
the aneurysm itself usually can not be seen on plain CT images.
Patients surviving the initial hemorrhage may deteriorate or die because of
rebleeding, vasospasm, or hydrocephalus.  The risk of rebleeding after SAH is 15-
20% within 2 weeks.  This can be avoided by treating the aneurysm in the early
phase, within 3 days (Öhman et al. 1989).  Angiographic vasospasm is seen in
almost 70% of the patients with SAH.  Delayed ischemic neurological deficit (DIND) –
sometimes still called clinical vasospasm – develops in one-fourth of the patients
(Kassell et al 1985).  The basic pathophysiology of DIND remains uncertain. It is an
elaborate condition, involving more brain arterioles and small vessels than merely
reflecting contraction in the main arteries.  It can cause clinical deterioration because
of decreased cerebral blood flow and may result in permanent cerebral infarction.
Nimodipine, a calcium channel antagonist has proven efficacious in preventing
vasospasm (Auer et al. 1986, Öhman et al. 1988, Pickard et al. 1990, Rinkel et al.
2002).  The effective treatment of vasospasm with induced hypertension,
hypervolemia, and hemodilution usually necessitates neurointensive care and
invasive monitoring and sometimes angioplasty (Song et al. 1997).  To carry out
these treatments more safely, the aneurysm must first be repaired.  Since the peak of
vasospasm is during days 6-8, surgery performed on days 4-10 may exacerbate the
vasospasm.  Hydrocephalus can be present already at admission to hospital,
especially in cases with intraventricular hemorrhage, or develop over the course of
months, slowing recovery.  The reported incidence of chronic hydrocephalus
requiring treatment with a shunt varies between 6% and 67 % (Tapaninaho et al.
1993, Vale et al. 1997, Dorai et al. 2003).
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2.2  Treatment of ruptured and unruptured aneurysms
Saccular aneurysms can be treated by either microsurgical clipping or
endovascular coiling (Figure 2).  In cases involving giant aneurysms, bypass surgery
in conjunction with trapping of the aneurysm (proximal ligation) may be needed.
Most aneurysms are, in theory, suitable for both microsurgical and endovascular
treatments.  However, surgical treatment is recommended in patients with a large
intracerebral hematoma, a severe hydrocephalus, or a giant aneurysm.  Both
methods are technically demanding and are associated with even fatal complications.
2.2.1  Microsurgical clipping
In 1937, Dandy was the first to clip an aneurysm.  The main evolution of
microneurosurgical clipping took place in the 1950s and 1960s, with improvements in
aneurysm clips (Norlen et. Olivecrona 1953, Heifetz 1963, Nyström 1966, Mayfield et
al. 1971) and development of operating microscopes (Donaghy et al. 1979, Kriss et
al. 1998).  The foremost publication by Krayenbühl and Ya?argil (1972) reported the
results of 231 microsurgically treated aneurysm patients between 1967 and 1971.
The mortality rate was only 4%, in a later study dropping further to 2% (Ya?argil et al.
1975).  However, no early surgery was performed and treatment was delayed up to 3
weeks after the initial SAH in most cases.
In microsurgical clipping a steel or titanium clip is applied to the neck of the
aneurysm, isolating it from the parent artery.  The long-term durability and efficacy of
clipping are very well known and good.  The annual recurrence rate of a completely
clipped aneurysm has been reported to be as low as 0.3% (Tsutsumi et al. 2001),
and the cumulative risk of rebleeding 2.2% in 10 years and 9.0% in 20 years after
clipping of a ruptured aneurysm (Tsutsumi et al. 1998). The cumulative risk of
bleeding from an originally unruptured aneurysm is 1.4% in 10 years (Tsutsumi et al.
1999) after complete clipping.  Angiographic long-term follow-up is usually not
performed for patients with clipped aneurysms after the initial imaging, unless the
patient with SAH is exceptionally young.  A recent report shows that the complete
occlusion rate after clipping is 88% (Kivisaari et al. 2004), unexpected neck remnants
remaining a challenge even in experienced hands (Lin et al. 1989).  It is important to
remember that these patients may also develop de novo aneurysms, especially if
such risk factors as smoking and hypertension are ignored or if the patient is very
young at the time of the initial bleeding (Rinne et al. 1993).  Clipping of previously
coiled aneurysms is sometimes indicated, but it requires even more meticulous
handling because the coil-mass interferes with visibility and approach, and the
aneurysm is usually attached to the surrounding parenchyma.
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2.2.2  Endovascular treatment
Endovascular treatment is performed by a trained interventionist
(neuroradiologist or neurosurgeon) as a member of a dedicated neurovascular team.
The endovascular approach can be used to treat aneurysms, arteriovenous fistulas
(AVFs), and arteriovenous malformations (AVMs) and can also be used in
conjunction with surgery (Marks et al. 1995).  Endovascular occlusion of feeding
arteries prior to surgery is also beneficial in highly vascular tumors.  In endovascular
treatment, the aneurysms is usually filled from inside the vessel lumen with
detachable coils, sometimes with the help of neck re-modeling with balloons or
stents.
2.2.2.1  History of endovascular treatment
The first steps in the treatment of intracranial vascular lesions (AVFs,
AVMs, and aneurysms) by an endovascular approach were taken by a Russian
neurosurgeon, Fedor Serbinenko, who started examining the potential of using flow-
directed inflatable balloon catheters in 1962 (Serbinenko et al. 1971, 1974).
Serbinenko used the balloon system to investigate collateral flow through the circle of
Willis and the effect of temporary and permanent occlusion of vessels.  In 1969, he
treated a carotid cavernous fistula with a nondetachable balloon.  He later developed
a mechanism for balloon detachment and hypothesized that it could be used for
aneurysm occlusion.  The technique was further developed by other researchers
(Romodanov et al. 1979, Debrun et al. 1981, Hieshima et al. 1986), and in order to
prevent the balloon from deflating, causing aneurysm recanalization or embolism to
the parent artery balloons were filled with a solidifying agent (Serbinenko et al. 1974,
Taki et al. 1980, Goto et al. 1988).  However, direct balloon occlusion of aneurysms
was associated with rather high mortality and morbidity.  In a series of 84 patients,
Higashida et al. (1990) reported a treatment-related mortality of 17.9%, mostly due to
aneurysm rupture, also in cases with no prior SAH.  Moreover, 10.7% of patients
developed stroke due to thromboembolism, parent vessel narrowing, or leakage of
solidifying agent from the balloon.  During the follow-up period of 3 to 68 months,
77.4% of the aneurysms continued to be permanently occluded, but 11.8% were in
need of re-treatment.
Metallic coils were later introduced as an alternative embolic material.
Copper wire had earlier been placed into aneurysms during an open craniotomy
(Mullan et al 1965, Hosobuchi et al 1979).  Endovascularly delivered metallic coils
were first used to occlude the entire parent vessel (Spaziante et al. 1986) and later to
selectively occlude the aneurysm (Takahashi et al. 1988, Dowd et al. 1990).  The first
coil types were “free” in the sense that once they were deployed into the aneurysms
with a pusher wire it was not possible to retrieve them.  Optimal positioning of the
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coils into the vascular lesion (aneurysm or AVM) is naturally important, and therefore,
mechanisms for coil retrieval were developed (Hawkins et al. 1986).
The most significant advance in endovascular technology for the treatment
of cerebral aneurysms was the development of the Guglielmi detachable coils
(GDCs) (Guglielmi et al. 1991a,b).  The GDC system consists of a soft platinum coil,
available in different sizes, which is connected to a stainless steel pusher wire by a
soft, uninsulated intermediate piece made of steel.  The coil can be repositioned in
the aneurysm several times and then motionlessly detached from the wire by
electrolysis of the intermediate piece.  The electrical current that causes the
electrolysis was also believed to cause substantial thrombosis of the aneurysm
(electrothrombosis).  The concept of electrothrombosis had been presented decades
earlier by Mullan et al. (1965, 1969) and Araki et al. (1966), who used the technique
in combination with stereotactic surgery or open craniotomy, but Guglielmi was the
first to combine electrothrombosis with endovascular mechanical occlusion of an
aneurysm.  Platinum was also suitable because of its biocompatibility (Loeb et al.
1982), radiopacity, and thrombogenicity compared with steel coils.  Moreover, the
soft platinum coil adapts to the shape of the aneurysm and is less traumatic than a
balloon or a stiffer steel coil (Guglielmi et al 1991a).  The initial results in 15 patients
were good (Guglielmi et al. 1991b), and in a matter of years the technique was
adopted by others and reports of larger series were published (Vinuela et al. 1997,
Cognard et al. 1998).
2.2.2.2  Safety and efficacy of endovascular coiling
A meta-analysis by Brilstra et al. (1999) showed a 12% mortality and
morbidity associated with coiling, including a 3.7% risk of permanent deficit and a
1.1% risk of death. Ischemic events and aneurysm perforations were the most
common causes of adverse outcome (Brilstra et al. 1999). It should be emphasized,
though, that these figures are from the very early era of endovascular treatment.
These figures may be acceptable, but a larger concern is the high rate of incomplete
occlusion, seen in 46% of cases (Brilstra et al. 1999), the high rate of angiographic
recurrence (recanalization), and the lack of long-term follow-up (i.e. several decades)
(Vanninen et al. 1999, Molyneux et al. 2002, Raymond et al. 2003, Taha et al. 2006).
Follow-up has proven to be necessary, with subsequent treatment frequently needed
(Vanninen et al. 1999, Raymond et al. 2003) to avoid rebleeding.  Also, completely
coiled aneurysms may undergo coil compaction and recanalization, leading to an
increased risk of rupture (Raymond et al. 2003).  It is still somewhat open how, when,
by whom, and how long these patients should be followed.
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The occlusion rate after endovascular treatment is usually evaluated with
the three-grade Raymond scale: 1) complete occlusion, 2) contrast agent filling in the
neck of the aneurysm, and 3) contrast agent filling in the sac of the aneurysm (Roy et
al. 2001) (Figure 1).
The rate of angiographic recurrence has been assessed in many short- and
medium-term studies.  Raymond et al. (2003) conducted a thorough retrospective
study of 501 aneurysms treated with GDC coils.  Overall angiographic recurrences
were found in 33.6% of patients after a mean follow-up of 12.31 ± 11.33 months.
Major recurrences, permitting re-treatment, were seen in 20.7% of patients after
16.49 ± 15.93 months.  Half (49.4%) of the major recurrences were re-treated, and of
these, a second recurrence was found in 48.6% of cases (at 15.56 ± 18.43 months).
Major recurrence significantly more often occurred in aneurysms larger than 10 mm
(34.4%) and aneurysms with necks wider than 4 mm (34.8%).  Ruptured aneurysms
showed major recurrence more often than unruptured ones (25.1% vs. 16.3%).
Complete initial occlusion was achieved in 35.9% of aneurysms, and in this group,
major recurrence was found in only 9.0%.  The aneurysm rupture rate, being 0.8%,
was far less than the angiographic recurrence rate, so even incomplete coiling may
protect against rebleeding.
Kuether et al. (1998) reported a series of 77 patients treated with platinum
coils and with an average angiographic follow-up time of 1.4 years.  Initial complete
occlusion was achieved in 40% of cases, and 14% of patients needed further
embolization.  Two patients (2/70 = 2.9%) suffered from rebleeding 5 months after
coiling; neither one of them exhibited complete initial occlusion.
In their study of 145 aneurysms treated with GDCs, Sluzewski et al. (2004)
found that large aneurysm volume is associated with low packing density and
increased risk of aneurysm recurrence.  Cognard et al. (1998) followed 169 coiled
aneurysms with an initial complete occlusion rate of 56% and observed recurrence in
14% of the lesions between 3 and 40 months.
 The long-term durability of coiling appear less certain than with clipping.
When assessing validity of older series, one should bear in mind that endovascular
techniques and devices have been – and still are – under constant development.  A
long-term, prospective, randomized trial comparing clipping and coiling has not yet
been performed.  Thus far, prospective studies have demonstrated follow-up times of
1 year (Koivisto et al. 2000) and 7 years (Molyneux et al. 2005).
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Figure 1:
Raymond scale, used for evaluation of aneurysm filling.
2.2.2.3 Further development of endovascular treatment
Embolizing aneurysms with detachable platinum coils is performed under
general anesthesia by first inserting a guiding catheter via femoral approach into the
cervical arteries (internal carotid artery or vertebral artery), after which a
microcatheter can be advanced into the aneurysm.  Through the microcatheter, the
aneurysm can be packed with a sufficient number of coils of different lengths and
diameters.  During the procedure intravenous heparin is routinely administered in
order to avoid thromboembolic complications.  Antiplatelet drugs can also be used.
Endovascular embolization should cause clotting of the blood inside the coil scaffold,
this blood cloth should become organized and fibrosed.  Moreover, for the treatment
results to be long-lasting, the neck of the aneurysm should become endothelialized.
Coiling was initially unsuited for aneurysms with an unfavorable dome-to-
neck ratio (width of dome / width of neck < 2.0) or a wide neck (>4mm) (Debrun et al.
1998, Wanke et al. 2003).  In 1997, Moret et al. (1997) introduced the so called
“remodeling technique”, in which an inflated balloon is temporary placed at the neck
of the aneurysm during coil placement to ensure that the coils do not protrude into
the parent artery.  The same thing can be accomplished by placing a self-expanding
stent at the neck of the aneurysm (Wanke et al. 2003) (Figure 2). Compared with the
balloon-expandable (coronary) stents used in a few early case reports (Higashida et
al. 1997, Mericle et al. 1998, Sekhon et al. 1998, Lanzino et al. 1999), deployment of
the self-expanding stent is less traumatic, and since the stent is more flexible, it is
safer to deliver and the risk of vessel dissection is smaller.  The self-expanding stent
is preloaded into the microcatheter.  A stabilizer wire is put into the microcatheter to
keep the stent in place.  Deployment of the stent occurs when the microcatheter is
pulled back while simultaneously keeping the stent in place with the stabilizer.  The
latest stents are electrically detachable and can be repositioned before detachment.
The microcatheter with the coil is pushed into the aneurysm already prior to stenting,
1 Complete            2 Residual Neck     3 Residual Aneurysm
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entrapping it between the stent and the vessel wall.  In this way, the microcatheter is
kept in place during coiling, but afterwards it is possible to remove it.  In addition to
heparin, patients undergoing stenting are given antiplatelet therapy consisting of
clopidogrel (30 days) and aspirin (rest of life) (Wanke et al. 2003).  Interestingly, it
has been shown that the stent alters the blood flow in the inflow zone of the
aneurysm, seen as stasis of contrast media inside the vessel (Wanke et al. 2003).
Therefore, in certain cases stenting alone can cure the aneurysm (Vanninen et al.
2003).  There is an ongoing development of intraluminal  flow-diverting stents, which
would principally be used alone without coiling (Kallmes et al. 2007).
In addition to making wide-necked aneurysms more favorable for
endovascular treatment, stenting also enables higher packing densities to be
achieved, which might provide better long-term results.  However, no data yet exist
on the long-term result of stenting.  Other inventions have also been devised in an
attempt to prevent recanalization, e.g. different modifications of the three-dimensional
shape of the coil (Malek et al. 1999, Cloft et al. 2000).  3D coils more easily produce
a basket into which subsequent filling-coils are easier to deploy, thereby improving
the packing density.
Figure 2:
Illustration of aneurysm clipping (a), and of stent assisted coiling (b).
2.2.2.4 Surface-modified coils in clinical use
Attempts have also been made to modify the surface of the platinum coils
since they are sometimes only surrounded by an unorganized thrombus, which does
not provide much anatomic support.  Second-generation coated coils were
developed to enhance maturation of the thrombus, formation of  fibrosis, and
endothelialization of the neck.
a
b
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The first second-generation coil introduced into clinical use was the Matrix
coil (Boston Scientific, Fremont, CA, USA).  Matrix is a GDC coil that is coated with
polyglycolic-polylactic acid (PGLA), a bioabsorbable polymeric material.  Materials
like this have been used for a variety of purposes, including sutures, implants, drug
delivery vehicles, and scaffolds for tissue engineering (Langer et al. 1993).
PGLA-coated coils were tested in two experimental aneurysm models, in
swine and rabbits (discussed further), before being introduced for use in humans.  In
human studies, the safety of PGLA-coated coils has been shown to be equal to
platinum coils (Katz et al. 2005, Linfante et al. 2005, Taschner et al. 2005, Pierot et
al. 2006), but the results on efficacy have been very confusing (Katz et al 2005,
Murayama et al 2006, Niimi et al 2006).  Murayama et al. (2006) achieved promising
results; 80.5% of aneurysms treated with PGLA-coated coils remained stable or
showed progressive occlusion after a mean follow-up of 8 months.  Moreover,
recanalization did not appear in aneurysms that were initially completely occluded.
However, Katz et al. (2005) and Pierrot et al. (2006) found the recanalization rate to
fall within the range of platinum coils, with rates of 14.3% (12 months) and 25.6% (14
months), respectively.  The worst results when using PGLA-coated coils were
reported by Niimi et al. (2006); their recanalization rate at 12 months was as high as
57.4%.  One explanation for the unsatisfactory result is that they had the lowest
primary occlusion rate, only 17.6%, compared with 56.3% in the Katz study.
Volumetric occlusion (packing density) seems to be an important factor also with
these second-generation coils.  The first large, prospective, randomized study
comparing PGLA-coated coils with platinum coils is about to begin.
Modifications of the Matrix coil have also been made, in the Cerecyte coil
(Micrus Endovascular, San Jose, CA, USA), polyglycolic acid (PGA) is loaded within
the coil loops rather than on the surface (Bendszus et al. 2006, Geyik et al. 2008).
Further studies are needed to verify the benefits of this coil compared with others.
Hydrogel (acrylic) polymer coating was developed to achieve higher
packing densities.  Hydrogel is biologically inert, but it  expands to provide additional
filling of the aneurysm.  It can expand up to 11 times its size and does not degrade.
These coils (HydroCoil, Microvention Inc., Aliso Viejo, CA, USA) have already been
in clinical use (Cloft et al. 2006, 2007a), but the longest follow-up thus far has only
been 6 months, and the coils were not simultaneously compared with other coils.
Despite the higher packing densities achieved with these expandable coils, the
overall recanalization rate was 28.1% at 3-6 months.  Surprisingly, with these coils,
the recanalization rate did not correlate with the packing density (18% vs. 19% in
aneurysms with packing densities >50% vs. <50%) (Cloft et al. 2007a), although the
rationale behind the use of HydroCoils was that the increased packing density would
reduce recurrences (Cloft et al. 2004).
Experimental coatings on coils, like extracellular matrix proteins, growth
factors, and modified cells, have also been developed, but to date have only been
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used in experimental animal models (Murayama et al. 1997, 1999, Kallmes et al.
1998b, Raymond et al. 1999, Abrahams et al. 2001) because of concern about
excess thrombogenicity and eventual complications (discussed in section entitled:
Coiling of experimental aneurysms).
2.2.2.5  Other endovascular methods
In addition to coils, stents, and balloons, other endovascular devices have
also been used.  Liquid embolic materials, which harden when they come into contact
with an aqueous solution (like blood), can also be used for the endovascular
occlusion of aneurysms, although these are more commonly used for occlusion of
AVMs and AVFs.  The first such agent (ethylene vinyl alcohol, EVAL) was presented
in 1989 for the endovascular occlusion of malformations (Taki et.al. 1990).  Today,
the most widely used substance is Onyx (ethylene vinyl alcohol copolymer dissolved
in dimethyl sulfoxide)(ev3, Plymouth, MN, USA), which was introduced in 1999 also
for the treatment of aneurysms (Moret J, Annual Meeting of the American Society of
Neuroradiology 2001).  In the treatment of aneurysms, Onyx is constrained to the
aneurysm with an inflatable balloon at the aneurysm neck.  The outer surface of the
Onyx cast starts to harden as the interior stays semi-liquid.  With further filling, the
added material breaks through the surface and makes the cast bigger.  Onyx is
injected at a very slow rate of 0.1 ml/min, after which the balloon is left inflated for 3
min.  The balloon is deflated for 2 min, after which the cycle can be repeated for as
many times as required to fill the aneurysm.  Once occlusion is complete, a 10-min
period is needed for the material to become completely solid.  After this, the balloon
is filled for the last time, in order to allow detachment of the microcatheter from the
Onyx cast by traction.
Molyneux et al. (2004) conducted a prospective multicenter study to
investigate the safety and efficacy of Onyx embolization of intracranial aneurysms.
Complete or subtotal occlusion was initially seen in 99% of cases; after 3 months,
this figure was 89%, and after 12 months 87%.  For large (>10 mm) and giant (>25
mm) aneurysms, the figure was 67% at 12 months.  The authors concluded that
Onyx can provide more durable occlusion in large, giant, and wide-neck aneurysms,
than endovascular coiling.  For giant aneurysms, the recanalization rate has been
33% if initially completely occluded and 59% if initially incompletely occluded with
coils (Murayama et al. 2003a).  Drawbacks with Onyx treatment are the technical
challenges and the multiple steps involved.  Since Onyx is inert and nonadhesive, the
results are likely to be highly dependent on initial occlusion rate.  Procedure- and
device-related permanent morbidity was 8.2% (8/92 patients), and mortality was
2.1% (2/92 patients).  Morbidity was due to leakage of Onyx into the blood flow,
extravasation of Onyx, and increased mass effect.  Of patients, 9.7% (9/92)
experienced delayed occlusion of the parent vessel, which was asymptomatic in
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5.4% (5/92).  Later studies have shown that also with Onyx the recanalization rate of
large and giant aneurysms is high, being 36% in ICA aneurysms (Cekirge et al.
2006).
2.2.3  Clipping versus coiling
The first prospective, randomized (Vanninen et al. 1999) study comparing
outcomes of early endovascular versus surgical treatment of ruptured aneurysms in
109 patients showed no significant difference in clinical outcome, measured by
Glasgow outcome scale (GOS), at 3 or 12 months (Koivisto et al. 2000).  Outcome
was more dependent on initial Hunt and Hess grade, aneurysm size, and presence of
vasospasm or hydrocephalus than on the treatment modality chosen.  The treatment-
related mortality was 2% in the endovascular group, compared with 4% in the
surgical group.  However, the angiographic occlusion rate was slightly lower in the
endovascular group.
The results of the larger ISAT study (International Subarachnoid Aneurysm
Trial), comprising 2143 patients with aneurysmal SAH, randomized between these
treatment modalities, were published in 2002 and 2005.  According to this multicenter
trial, a significantly larger number of patients were dependent or dead at 1 year in the
surgical group (30.6%) than in the endovascular group (23.7%) (Molyneux et al.
2002, 2005).  However, complete occlusion of aneurysms was seen in 82% of
patients in the surgical group, as opposed to only 66% in the endovascular group.
Moreover, the risk of rebleeding was higher in the endovascular group than in the
surgical group.  The authors concluded that if the anatomy of the aneurysm indicates
a high likelihood of success by endovascular techniques, the patients should be
offered this option.  There are, however, some concerns regarding this study, and so
far it does not ultimately prove the superiority of endovascular treatment.  In ISAT,
the majority of patients (7416 / 9559) were excluded from the study; the study
population therefore consisted of patients in better condition and with more anterior
circulation aneurysms than on average.  The majority of the excluded patients were
eventually treated surgically.  A major part of the participating centers and enrolled
patients were from the UK, and thus, national circumstances confounded the results.
A large number of centers performing microsurgical clipping with a low annual case
flow were included, raising the question about the quality of their performance.
Experience and high case flow have been demonstrated to lead to better outcome
(Solomon et al. 1996, Cowan et al. 2003).  The lower number of individual centers
performing endovascular coiling all received a higher number of patients and were
quickly gaining more experience.  The ISAT study has been criticized as more or less
being a comparison of expertise between these treatment modalities in the British
healthcare system.
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2.3  Experimental aneurysm models
2.3.1.  Aneurysm models for the study of cerebral artery aneurysms
It has earlier been believed that the pathobiology of human SCAAs could
be elucidated through work in experimental aneurysm models.  However, although
animal models may mimic some aspects of true aneurysms, such as morphology,
hemodynamics, or wall cellular content, they never exhibit all of these characteristics
at once.  They also do not possess the same activated pathways at the cellular level
as human SCAAs.  Only in recent years has the complexity of the etiology and
evolution of human SCAA really started to be appreciated.  SCAAs evolve, degrade,
and rupture when the processes weakening the aneurysm wall exceed those
strengthening it.  Today, the most important objective of experimental animal models
has been the testing of endovascular devices for aneurysm occlusion.  Coiling should
cause thrombosis and fibrosis of the aneurysm and endothelialization of the
aneurysm orifice.  In order to be able to extrapolate the results to humans, the animal
model must resemble human SCAAs as closely as possible.
There have been many attempts to create experimental aneurysm models
in animals.  The first model was established in 1954 when German and Black tried to
elucidate the etiology of human SCAAs by studying the hemodynamics of the
aneurysms.  They used a venous pouch from the external jugular vein as a graft and
constructed five experimental aneurysms in the common carotid arteries of dogs.
The aneurysms remained patent for up to 5 months and were suitable for
measurement of intra-aneurysmal and intra-arterial pressure and preliminary
assessment of the motion of flow inside the aneurysm by cinefluorographic methods.
However, they did not perform histological analysis.  The venous pouch model has
later been modified in many ways and adapted to different species of animals (Table
1).  Forrest et al. (1989) introduced a technique in which the left and right common
carotid arteries were anastomosed with each other, creating an artificial bifurcation
for aneurysm construction.  They also tried to relocate the aneurysm segment into
the subarachoid space at the cranial vertex, but, unfortunately, these aneurysms did
not remain patent (O’Reilly et al. 1981).  Experimental intracranial aneurysms were
created with a 55% success rate by transplanting venous grafts to the basilar artery
(lingual-basilar branch) of dogs by Nishikawa et al. (1977).  Macdonald et al. (1998)
created a multiple aneurysm model using venous grafts in the carotid arteries of
dogs.  By anastomosing the cranial parts of the right and left common carotid arteries
with each other and anastomosing the caudal end of the right common carotid artery
to the caudal side of the newly formed arterial loop, they were able to form a Y-
shaped vessel, which then was used as a platform to create both terminal and
sidewall aneurysms in the same animal.
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Arterial experimental aneurysms have also been created in the carotid
arteries of rabbits without the need for an anastomosis, by ligating either the common
carotid or the external carotid artery and infusing it with elastase (digestive enzyme)
in order to destroy the internal elastic lamina and weaken the wall (Cawley et al.
1996, Altes et al. 2000, Hoh et al. 2004).  A combination of intraluminal elastase and
collagenase digestion has also been used (Yang et al. 2007), as has topical
administration of elastase on the adventitial surface of the vessel (Miskolczi et al.
1998).  Although these aneurysms remain patent for a longer time than the venous
pouch aneurysms and due to their thin-walled nature are even susceptible to rupture,
they have the least pathobiological resemblance to real SCAAs.
In humans, most aneurysms arise at arterial bifurcations, but some are pure
sidewall aneurysms (e.g. Pcom and ICA aneurysms).  Vascular pressure and sheer
stress are different in bifurcation aneurysms than in sidewall aneurysms.  The animal
model should mimic the hemodynamic conditions of human SCAAs, and they have
been produced in both ways.
Large animals, like dogs, sheep, and pigs, are much more expensive than
rabbits, rats, or mice.  The vasculature of the smallest animals (mice) is, however, not
suited for the use of standard endovascular devices.  Hence, mice can and should be
used only in histopathological studies (Frösen, Marjamaa 2006a)
2.3.2  Other aneurysm models
The necessity of experimental aneurysm models for testing of improved
surgical methods, like grafting and wrapping, has also arisen in the field of aortic
aneurysm surgery.  Experimental aneurysms have been produced by injecting
nitrogen mustard into the adventitia of the thoracic aorta in dogs (McCune et al.
1953).  This necrotizing agent was extremely potent and caused aneurysm formation
and rupture within 4-14 days.  Later fuciform abdominal aneurysms in rats have been
produced more elegantly by elastase perfusion (Anidjar et al. 1990).
2.3.3  Coiling of experimental aneurysms
Coiling has been performed in animal models to evaluate histological
changes with platinum coils and to test novel devices.
The first study, focusing on long-term histological changes in coiled
experimental aneurysms, was performed in a canine jugular vein pouch model
(Mawad et al. 1995).  In this study, 10 aneurysms were coiled with various amounts
of coils, and total occlusion was achieved in 9 of 10 cases.  During the 6-month
follow-up recanalization had occurred in 3 cases.  However, in all cases, a neointima
covering the coils was seen, but there was only a mild inflammatory reaction and
small amount of desired thrombus organization.
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Reul et al. (1997) compared GDC coils with tungsten coils in a rabbit
model.  Surprisingly, they found very high rates of incomplete occlusion in both
groups (12/17), at 3 and 6 months.  The lumen of GDC-coiled aneurysms was open
in 6 of 8 cases and thrombus was present between the loops of the coils.  In addition,
a neointima was found in only one GDC-coiled aneurysm.  This is consistent with
Tamatani et al. (1997), who showed in an in vitro work that there was no endothelial
proliferation on the surface of platinum coils.
Byrne et al. (1997) used the swine model to compare GDC and tungsten
coils with untreated controls.  They achieved a total initial occlusion in 10 of 18 coiled
aneurysms.  By the end of the 2- to 7-week follow-up, the remaining eight coiled
aneurysms and also the five controls were completely occluded.  They performed
histological analysis at 2, 4, and 7 weeks.  The inflammatory response in coiled
aneurysms was greater during the first time-point than during later time-points.
During later time-points the initial unorganized thrombus was replaced by fibrous
tissue in-growth from the margins.
Testing of novel devices started in the mid-1990s, when the surface of GDC
coils was coated with extracellular matrix proteins like collagen (Ahuja et al. 1993,
Dawson et al. 1996, Szikora et al. 1997).  The hypothesis was that these
modifications would increase the thrombogenicity of the coil, accelerate fibrosis in the
aneurysm and stimulate endothelialization of the aneurysm neck.  The coatings were,
however, weak and could be easily scraped off during delivery.  To overcome this
problem Murayama et al. (1997) used a physiochemical surface modification by ion
implantation, which made the proteins adhere more tightly to the coil surface.  They
compared fibronectin-, fibrinogen-, albumin-, laminin-, vitronectin- and collagen-
coated coils and found that all these coatings improved cellular adhesion and
proliferation, with fibrinogen being the most thrombogenic.  GDC coils have also been
coated with growth factors and fibroblasts (Abrahams et al. 2001, Kallmes et al.
1998a).  Furthermore, sponges impregnated with growth factors have been used to
pack experimental swine aneurysms (Venne et al. 1999).  Sponges with fibrinogen,
vascular smooth muscle cells, and peripheral blood mononuclear cells were also
used in jugular vein aneurysms in dogs (Raymond et al. 1999).  All of these studies
showed improved results in thrombus organization, neck endothelialization, and
tissue integration into the aneurysm.  However, none of these devices have been
approved for clinical practice because of concern about excessive thrombosis and
thromboembolic complications.  Protein and especially cellular coatings are stripped
when the device is passed through a microcatheter, both reducing the effects of
treatment and increasing the risk of complications.
The next step has been the use of bioabsorbable polymeric materials such
as PGA (polyglycolic acid) and PLA (polylactic acid) (Murayama et al. 2001).  These
materials are widely used in the field of tissue engineering and serve as scaffolds on
which cells can grow and reconstitute tissues (Langer et al. 1993).  The rationale is
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that the polymer should permit cellular adhesion and growth and be reabsorbed after
it has served its purpose to avoid chronic inflammation.  Depending on the
composition of the polymer, the absorption rate and the strength of the inflammatory
reaction can be varied (Murayama et al. 2002).  As a result, the Matrix coil coated
with 90% PGA and 10% PLA was developed.  The Matrix coil is absorbed slowly and
elicits a moderate tissue reaction (inflammation).
These experimental devices were tested in jugular vein graft aneurysms in
swine and elastase-induced carotid artery aneurysms in rabbits before clinical use.
In the swine jugular vein model, the aneurysms were followed up by DSA for 14 days
to 6 months and analyzed histologically at the end.  During follow-up the tissue layer
covering the neck was found to be thicker in the PGLA group and the aneurysms
showed a more extensive area of thrombus organization and larger amount of
inflammatory cell infiltration on day 14.  In the rabbit carotid artery model, similar,
strong inflammatory reactions around the PGLA-coated coils were found at 6 and 10
weeks, and neck tissue deposition in all PGLA-coiled aneurysms was present at 2
weeks.  All of these changes were considered to be beneficial.
2.3.4  Rupture of experimental aneurysms
Standardizing the risk of rupture in experimental animal models has been
impossible.  The use of digestive enzymes (elastase, collagenase) or necrotizing
agents severely weakens the vessel wall, causing a risk of rupture otherwise very
seldom seen in experimental aneurysms.  However, the variance in the time of
rupture is very large even within the same study.  Yang and collaborators (2007)
observed the rupture of the first aneurysm within 24 h, while another ruptured 4
weeks after construction.  It is not possible to mimic the natural fate and rupture rate
of human cerebral aneurysms, and these models reflect real SCAA poorly.
Moreover, this kind of heavy digestion is not seen in human SCAAs.
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Table 1. Experimental aneurysm models.
Author Animal Aneurysm location Technique Endovascular
coiling possible
German, Black
N Eng J Med 1954
Dog Common carotid artery
Sidewall
External jugular vein pouch
surgically anastomosed,
V-incision
Angiography
performed
Nishikawa M
Surg Neurol 1976
Rat Common carotid artery
Bifurcation
Vein patch graft surgically
sutured to artery
No
Nishikawa M
Surg Neurol 1977
Dog Basilar artery
Sidewall and bifurcation
Vein graft surgically sutured to
artery
Possible
Kerber CV
Invest Radiol 1977
Dog Common carotid artery
Sidewall
External jugular vein pouch
surgically anastomosed,
I-incision
Angiography
performed
Stehbens WE
Surg Gyn Obst 1979
Sheep Common carotid artery
Sidewall
Modification of German et. al.
in sheep
No
Stehbens WE
Stroke 1981
Rabbit Aortic bifurcation External jugular vein pouch
surgically anastomosed
No
Young PH
Microsurgery 1987
Rat Carotid artery
Sidewall
Vein pouch sutured in variety
of ways
No
Forrest, O’Reilly
AJNR 1989
Rabbit Common carotid artery
Bifurcation
External jugular vein pouch
surgically anastomosed in
artificial bifurcation
Angiography
performed.
Intravascular laser
attempted
Anidjar
Circulation 1990
Rat Abdominal Aorta
Fuciform
Elastase perfusion No
Graves
AJNR 1993
Dog Common carotid artery
Terminal
External jugular vein pouch
surgically anastomosed to
artificial arterial arch made
from right and left carotid
Embolization with GDC
performed
Guglielmi
Neuroradiology 1994
Swine Common carotid artery
Sidewall
Modification of German et. al.
Arteriotomy made through
fundus of vein graft
Endovascular approach
possible
Massoud
AJNR 1994
Swine Bifurcation and terminal External jugular vein pouch
sutured in five different ways to
carotid artery or ascending
cervical artery
Not attempted
Tenjin
Stroke 1995
Cawley
AJNR 1996
Monkey
Rabbit
Carotid artery
Sidewall
External carotid artery
Bifurcation
Femoral vein pouch surgically
sutured to artery
Elastase perfusion of carotid
stump trough femoral
catheterization
Embolization with GDC
performed
Spetzger
J Neurosurg 1996
Rabbit Common carotid artery
Bifurcation
External jugular vein pouch
surgically anastomosed in
artificial bifurcation
Embolization with GDC
and MDC performed.
Macdonald
Stroke 1998
Dog Common carotid artery
Terminal and sidewall
Modification of Graves et. al.
Includes sidewall aneurysms
Embolization with GDC
and CAP performed
Miskolczi
Neurosurgery 1998
Rabbit Common carotid artery
Superior thyroid artery origin
Bifurcation
External application of elastase
to artery wall
No
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Altes
AJR  2000
Rabbit Common carotid artery
Terminal
Modification of Cawley et. al.
Retrograde catheterization of
common carotid. Temporary
proximal control with balloon
Yes
Hoh
Acta Neurochirurgica 2004
Rabbit Common carotid artery
Terminal
Modification of Altes et. al.
Temporary proximal ligation
with microclip
Angiography
performed
Frösen Marjamaa
Neurosurgery 2006
Rat,
Mouse
Abdominal Aorta
Sidewall
Arterial graft surgically
anastomosed
Embolization with GDC
performed
Yang
Jzus B  2007
Rabbit Common carotid artery
Terminal
Modification of Graves et. al.
Arterial graft from carotid artery
incubated in elastase
GDC   Guglielmi Detachable Coil
MDC   Mechanically Detachable Coil
CAP   Cellulose Acetate Polymer
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2.4  Vascular imaging
In clinical practice, SAH or an intracerebral hematoma can be reliably
diagnosed with computed tomography (CT) (van der Wee et al. 1995), but to
visualize the vascular lesion itself (aneurysm, AVM, AVF), angiographic methods are
needed.  The gold standard for vascular imaging is digital subtraction angiography
(DSA), but it is being gradually replaced by noninvasive alternatives such as
magnetic resonance angiography (MRA) and computed tomography angiography
(CTA).
2.4.1  Computed tomography angiography (CTA)
Since CTA is fast and readily available, it is often the first examination
performed when a vascular lesion is suspected.  The sensitivity to detect aneurysms
>3 mm is very good (96%), but sensitivity decreases considerably when aneurysm
size is ?3 mm (61%) (White et al. 2000).  With newer multislice helical CT scanners,
the image resolution has improved (Kato et al. 2002), and even aneurysms as small
as 2 mm can be detected with 99% sensitivity and 99% specificity (Kangasniemi et
al. 2004).  However, CTA cannot be used for follow-up of aneurysms treated with
platinum coils because of the amount of artifact created by the coils.  The follow-up of
coiled aneurysms can only be performed with DSA or MRA, and these methods will
be discussed and reviewed further in the following sections.  In clinical use, CTA´s
capability of showing small perforators or flow dynamics (e.g. in PCom) is limited.
2.4.2  Digital subtraction angiography (DSA)
DSA of cerebral vessels is usually performed through a femoral puncture.
The catheter is advanced via the aorta to the carotid or vertebral arteries.  Multiplane
or rotational x-ray images are acquired after injection of contrast media.  The pre-
contrast image, including soft tissue and bony structures, is “subtracted” from the
subsequent images, giving the final images, also in 3D, in which only blood vessels
are apparent.  Frequently repeated images add a dynamic component to the
examination; this is important when assessing flow inside an aneurysm, arterial filling
in cases with suspected embolism, or early venous filling associated with AVMs.  If a
vascular lesion is detected during the DSA imaging session, immediate endovascular
treatment can be provided.  Because DSA is invasive, it is associated with non-
negligible morbidity and mortality, mainly due to thromboembolism, vessel spasm, or
vessel dissection.  Permanent neurological complications are reported to vary from
0.1% to 0.5%, and transient neurological complications are four times as common
(0.4-2.6%) (Earnest et al. 1984, Dion et al. 1987, Grzyska, et al. 1990, Heiserman et
al. 1994; Willinsky et al. 2003).  Notably, one smaller study with high-risk patients
31
(carotid stenosis, previous transient ischemic attacks) reported transient neurological
complications in 12.2% and permanent complications in 5.2% of patients (Faught et
al. 1979).  Other complications are also encountered (Leffers et al. 2000), such as
hematomas at the puncture site, renal failure due to use of iodine-based contrast
agents, or allergic reactions to the contrast agent.  Other drawbacks are that it is
time-consuming, which is not desirable for an unstable patient and might even
necessitate general anesthesia.  The radiation dose to the patient is highly
dependent on the complexity of the procedure (angiography vs. endovascular
treatment), but the average effective dose for a four-vessel angiogram (3.6 mSv)
(Marshall et al. 1995) falls within the range of a multislice CTA exam (2.2 and 4.3
mSv for 4- and 64-slice CTAs respectively) (Klingebiel et al. 2008).  Both CTA and
DSA require the use of iodine-based contrast agents.  DSA can be performed with
smaller amounts of contrast agent and might be used even for patents with mild renal
failure.
2.4.3  Magnetic resonance imaging (MRI)
The MRI technology was created by Paul Lauterbur and Peter Mansfield in
the 1970s and the first study on a human subject was performed in 1977.  The
creators were awarded the Nobel Prize for Medicine in 2003.  MRI enables detailed
images of the body to be acquired without harmful radiation.  The contrast between
different soft tissues is also superior to CT, making MRI suitable for depicting
anatomy.  MRI is therefore often used for imaging of the nervous system and
musculoskeletal system.  MRI is also well-suited for detecting pathologies like
tumors.  MRI is generally safe, but the strong magnetic field interacts with metallic
objects.  It is contraindicated for the patient to have metal implants or implanted
electrical devices e.g. cardiac pacemakers.  The relatively long imaging time requires
compliance from the patient, as in the case of DSA.
2.4.3.1  Principles of MRI
When a subject is placed into the magnet, it exerts a magnetic field of its
own, which is parallel to the external magnetic field (longitudinal). This field is a result
of the alignment of protons, in other words hydrogen nuclei (1H), which are found in
water-rich tissues.  When a radio frequency pulse (RF pulse) is sent into the subject,
it excites the protons and causes a decrease in the longitudinal magnetization and
appearance of a transversal magnetization. The transversal magnetization is a result
of the synchronization of the precession of the protons, which are put into ”phase” by
the RF pulse.  The newly developed transversal magnetization precesses and
causes a magnetic resonance (MR) signal, that can be detected.  When the RF pulse
is switched off, the system goes back to its original state, the longitudinal
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magnetization increases (= T1 relaxation) and the transversal magnetization
decreases (= T2 relaxation).  In a spin-echo pulse sequence, the normal 90° RF
pulse is followed by a 180° refocusing pulse at TE/2.  When this refocusing pulse is
applied, the sign of the phase is reversed.  Therefore, the precessing protons begin
to rephase again and phase coherence is re-established at TE.  Different tissues
have a different ratio of free to bound hydrogen nuclei, and therefore, different T1
and T2 relaxation times.  For water, both T1 and T2 are long, whereas for fat, they
are short.
The contrast in MRI is affected by intrinsic (tissue-dependent) and extrinsic
(user-selectable) factors.  The intrinsic factors include the relaxation times (T1, T2,
T2*), proton density and flow characteristics.  Important extrinsic factors are repetition
time (TR), echo time (TE), pulse angle (PA), sequence type, number of averages and
coil type. TR is the time between two RF pulses in a pulse sequence.  TE is the time
from the RF pulse to the maximum intensity of spin-echo.  TE less than 30 ms is
considered short and TE longer than 80 ms is considered long.  With short TR and
short TE the image is T1-weighted, whereas with long TR and long TE the image is
T2-weighted.  The image is proton density-weighted when TR is long and TE is short.
With short TE, the difference in T2 relaxation time does not influence contrast much.
With long TE, the total signal intensity becomes smaller, the signal-to-noise ratio
(SNR) becomes weaker, and the image becomes grainy.  The spatial information in
the image is due to the slice-, phase-, and frequency encoding gradients .
In MRI, contrast can be enhanced by the use of gadolinium contrast agent.
gadolinium acts by shortening the T1 and T2 relaxation in the tissue that it
penetrates.
2.4.3.2  Magnetic resonance angiography
Magnetic resonance angiograms can be acquired either without the use of
a contrast agent (flow-dependent techniques and fresh blood imaging) or with the
use of intravenously injected gadolinium (contrast-enhanced MRA).  In flow-
dependent techniques (time-of-flight [TOF] and phase contrast angiography)
advantage is taken of the fact that blood flows through the vessels during the
acquisition.  Both flow-dependent techniques are based on gradient-recalled echo
sequences.  These techniques were originally created at the end of the 1980s (Laub
et al. 1988, Dumoulin  et al. 1989a, b). In the more recently developed fresh blood
imaging (FBI) technique (Miyazaki et al. 2000), simultaneous ECG monitoring is used
to acquire diastolic bright-blood images, systolic black-blood images and a
subtraction image showing only the arteries.
TOF-MRA images are T1-weighted and blood should appear as hypo-
intense, but because of the flow through the imaging volume, blood does not have
time to become excited to the full extent, therefore appearing as hyper-intense.  As
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long as the TE values are kept relatively low, the signal intensity from the stationary
background tissue will be very low, but the signal from fresh inflowing blood will be
high and appear bright on the image.  In a 3D imaging slab, the flow-related
enhancement is highest near the inflow surface, but the signal gradually decreases
(in more distal vessels) as the magnetized blood becomes saturated.  The potential
pitfalls in TOF-MRA, are related to the fact that wherever blood flow is slow, the spins
(protons) in blood will become saturated along with the background tissue, and there
will be no contrast.  This is a problem when trying to visualize venous structures and
sometimes also results in a signal-void within large aneurysms and is the reason why
optimization of imaging protocols needs to be done.  Fat suppression and
magnetization transfer can be used for additional suppression of fat- and protein-
containing background tissues.
Phase contrast angiography is more time-consuming than TOF-MRA.
Phase contrast exploits the transverse magnetization dephasing of the moving spins
which are subjected to a magnetic field gradient.  In conventional sequences, the
phase is only related to the spatial information.  By the use of an additional bipolar
RF pulse, the moving blood acquires a flow-induced phase.  A second flow-
compensated acquisition without the bipolar pulse is needed to complete the
sequence.  The final image, a subtraction of these two,  has a very good suppression
of the background and shows the vascular structures well.  Phase contrast
angiography enables the measurement of flow velocity and the detection of flow
direction.  However, image quality is dependent on the velocity-encoding coefficient
(VENC [cm/s]), which the user needs to predetermine to a value near the real value.
This might be difficult in situations with nonphysiological flow, e.g. in an aneurysm
(Willinsky et al. 2003).
Contrast-enhanced MRA (CE-MRA) (Prince et al. 1993) gives a more
accurate anatomical image of the vessels and possible aneurysms than flow-
dependent techniques.  The contrast agent is injected intravenously, and the image
is acquired after a certain time.  The determination of the time interval is the limitation
of this technique.
Fresh blood imaging (FBI) is done with a 3D ultrafast spin-echo sequence
with a half Fourier plane and requires prospective cardiac triggering, but is performed
without any contrast agent.  In FBI, the background is suppressed with an inversion
pulse.  The imaging volume needs to be parallel to the vessel.
The use of different MRA methods is justified since the information
gathered may be complementary, and some methods are also better suited for
venous imaging (Willinsky et al. 2003).
The latest development in the imaging of vascular pathologies is the use of
USPIOs (Ultrasmall Superparamagnetic Particles of Iron Oxide) as a contrast agent
in order to detect inflammatory cell infiltration in the arterial wall (Trivedi et al. 2006).
USPIOs are taken up by macrophages present in, for example, atherosclerotic
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plaques, and the iron component in these particles causes a susceptibility artifact that
can be detected with MRI.
2.4.3.3  Clinical use of MRA in the imaging of SCAAs
A meta-analysis by White et al. (2000) showed almost a decade ago that
MRA is equally sensitive to CTA in visualizing aneurysms > 3 mm (94% vs. 96%).
However, aneurysms < 3 mm were visualized only in 38% of cases with MRA,
compared with 61% with CTA.  More recent studies have shown that the sensitivity is
better when using MR scanners with higher field strength (3 Tesla) and closer to CTA
(aneurysms < 3 mm MRA 67% vs. CTA 58%) (Hiratsuka et al. 2008).
The suitability of MRA (especially TOF-MRA) for the pre- and post-
procedural evaluation of coiled aneurysms has been evaluated (Deutschmann et al.
2007).  Using a 1.5 T scanner, Deutschmann et al. (2007) observed residual necks
with a 94% sensitivity in cases where the aneurysm was > 3 mm, but only in 63.6%
of cases where aneurysms were < 3 mm.  They used both TOF-MRA and CE-MRA
and found no difference between these techniques.  Earlier studies did not correlate
aneurysm size with the diagnostic accuracy of recanalization, but the overall
sensitivity (72-97%) and specificity (91-100%) were within the same range (Kähärä et
al. 1999, Anzalone et al. 2000, Boulin et al. 2001).  In conclusion, TOF-MRA is
especially suitable for follow-up of coiled aneurysms in cases with good initial
correlation to DSA (Anzalone et al. 2000).  Later, with the introduction of 3T
scanners, reports have demonstrated that TOF-MRA is as suitable for follow-up as
DSA (Ferré et al. 2008).  CTA is not suited for this purpose because it is susceptible
to artifacts created by the coils.  However, the artifact from aneurysm clips is less
obvious in CTA than in MRA.
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3.  Aims of the study
1.   To optimize MRA imaging of the cerebral arteries and aorta of mice and to scan
      collagen 1a1-deficient mice for spontaneous aneurysms.
2.   To develop an experimental aneurysm model in rats, characterize its histological
       features during a long-term follow-up, and evaluate its suitability for the testing of
       endovascular devices.
3.   To optimize a MR imaging protocol for the follow-up of coiled rat aneurysms,
including a high-resolution TOF MRA sequence for volumetric measurement of
neck remnants.
4.   To compare bare platinum GDC coils with PGLA-coated coils in the experimental
rat aneurysm model.
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4.  Materials and methods
4.1  Study design
Study I
Mice with collagen I deficiency (Col-Int?) are prone to develop vascular
defects.  Collagen type I and III represent 80-90% of the total arterial wall collagen
and are responsible for its tensile strength.  Due to bleeding into the thoracic cavity,
54% of Col-Int? mice die before the age of 18 months.  We optimized the protocol for
imaging the entire aorta and the cerebral arteries of mice using spin-echo, pulse-
echo and TOF-MRA sequences.  Our aim was to determine whether Col-Int? mice
develop detectable aneurysms in their aorta or other vessels, including the cerebral
arteries, before they die.  Moreover, we wanted to evaluate, whether this genetic
mouse model helps to elucidate the hemodynamic conditions and pathobiological
mechanisms involved in the formation of aneurysms and whether it can be used for
the development of therapeutic methods.
Study II
Our goal was to develop an experimental aneurysm model in rats, that
would be suitable for endovascular coiling.  We characterized the histology of the
aneurysm model and evaluated its long-term patency (Study II and unpublished
data).  Moreover, by adapting the aneurysm model to transgenic mice, we evaluated
the contribution of bone marrow-derived progenitor cells in the formation of the
neointima and the effect of atherosclerosis (discussed further in the thesis of J
Frösen (2006c)).
Study III
Our goal was to develop a reliable MR imaging protocol for the follow-up of
coiled experimental aneurysms in rats.  We quantified the volume of the aneurysm
neck remnants with 3D TOF-MRA.  To enable the volumetric analysis, we had to
reach a voxel size of < 150 µm.  We performed optimization of the MR-imaging
protocol along with the novel 3D TOF-MRA sequence in a simulation-based manner.
Study IV
The experimental rat aneurysm model was used to compare the efficacy of
platinum and polyglycolic-polylactic acid-coated (PGLA) coils in aneurysms with
initially deliberate incomplete occlusion.  During a 4-week follow-up animals were
noninvasively imaged six times with the optimized MRI protocol.  We performed
volumetric analysis of the neck remnants during the follow-up and analyzed the
aneurysms histologically at the end.
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4.2  Experimental animals and surgical procedures
4.2.1  Mice
In study I, collagen deficient (Col-Int?) mice were homozygous for a 1283
bp deletion in the 1462-bp-long first intron, of the Col1a1 gene encoding the
procollagen ?1 chain of collagen type I.  A silent mutation, which created a new XhoI
site, was introduced in the Col1a1 gene to assist in the detection of the mutant allele
in genomic DNA.  The mice were genotyped by polymerase chain reaction
amplification and restriction digestion of DNA.  A group of 5 homozygous ???? ?mice
and 5 age- and weight-matched control +/+ mice were examined at the age of 16
months.
4.2.2 Rats
To create experimental aneurysms suitable for endovascular coiling, we
used male Wistar rats (Harlan, Horst, Netherlands), weighing 300-450 g at the time of
the aneurysm construction and coiling procedures (Studies II-IV).  The procedures
were approved by the Committee for Animal Welfare at the University of Helsinki,
Finland.
4.2.3 Aneurysm construction and endovascular coiling
Aneurysms were constructed into the abdominal aorta of rats by
transplanting an arterial graft from the descending thoracic aorta of sacrificed donor
animals (Figure 3).  First, the infrarenal part of the abdominal aorta of the recipient
was exposed and room for vascular clamps was made.  The donor animal was given
an overdose of anesthetics, after which a bilateral thoracoabdominal incision was
made.  The descending thoracic aorta was exposed, the left subclavian artery
identified, and a loose ligature was placed 5 mm distal to it.  In this model, the length
and aspect-ratio of the aneurysm can be varied (w x l = 2-3 x 3-6 mm) depending on
the site of the ligature.  The graft was removed and transplanted to the side of the
abdominal aorta of the recipient.  The graft walls were carefully aligned with the
orifice of the arteriotomy.  The anastomosis was made by using continuous 10-0
nylon sutures.  After opening the vascular clamps, pulsation in the aneurysm and flow
in the aorta were verified.  A digital video camera (Sony Exwave? HAD SSC-
DC58AP, Japan) attached to the stereomicroscope was used to document the final
result at magnifications of 6-40x.  Eighty-one aneurysms were constructed when
setting up the model; their histology and patency, during follow-up, were confirmed.
Six aneurysms were constructed in order to set up the coiling model (Study II +
unpublished data).  In study III 10 rats were used and in Study IV 40 rats.  The
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procedure in mice was identical (n=55), but the graft was smaller (1-1.5 x 2.5-3 mm),
and it was sutured with interrupted 11-0 nylon sutures (Study II).
In Study IV the aneurysm grafts were coiled prior to their removal from the
donor animal.  A cannula with the catheter, including the coil, was inserted into the
upper abdominal aorta in a retrograde manner.  The aorta was flushed free from
blood with heparinized saline, after which coiling was performed under visual
inspection to ensure that the coils always align in the same way.  The coils were
detached by electolysis.  Each aneurysm was coiled with either one PGLA-coated
coil (Matrix? coil, SR-2mm x 2cm; Boston Scientific Corporation, CA, USA) or one
platinum coil (GDC? coil, SR-2mm x 2cm; Boston Scientific Corporation, CA, USA).
When the ligature around the fundus was tightened, it also grasped the end of the
coil, ensuring that the coils did not protrude into the parent artery.  We deliberately
left a 1.5-mm-long neck remnant in each aneurysm because we wanted to compare
the effect of the coils in a situation with an incomplete primary result.  An effective coil
should stimulate gradual occlusion even in a situation like this.  Moreover, with an
initial neck remnant, we were able to detect cases in which improper suturing of the
anastomosis resulted in thrombosis at the site of the suture line.  Whereas a gradual
occlusion stimulated by the coils should begin at the interface between the coil mass
and the blood.
Figure 3:
Construction of experimental aneurysm into the abdominal aorta of a rat.  Exposure of the aorta (A),
arteriotomy (B), suturing of the graft (C), finished anastomosis (D) and pulsating aneurysm after
removal of the vascular clamps (E).
4.2.4 Anesthesia
Anesthesia was used for both the surgical procedures and for the MR-
imaging. During the anesthesia the animals were breathing spontaneously.
Mice were anesthetized with Hypnorm? (1.2 ml/kg; a mixture of fentanyl
citrate 0.315 mg/ml and fluanisone 10 mg/ml, s.c.; Janssen Pharmaceutica Ltd.,
Beerse, Belgium) and Dormicum? (15 mg/kg; midazolamhydrochloride 5 mg/ml, i.p.;
Roche, Basel, Switzerland).
A                  B              C  D                     E
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Rats were anesthetized by using Domitor? (0.5 mg/kg; medetomidine 1
mg/ml, s.c.; Orion Pharma, Espoo, Finland) and Ketalar? (75 mg/kg; ketamine 50
mg/ml, i.p.; Pfizer, New York, NY,USA).  Animals were allowed to wake up on their
own in a warmed incubator and were given Temgesic? (5 mg/100g for mice and 0.3
mg/kg for rats; buprenorfin 0.3 mg/ml, s.c.; Schering-Plough, Kenilworth, NJ, USA)
for postoperative pain.
4.3  Animal MRI
MRI was performed with a 4.7 T MR scanner (PharmaScan, Bruker?,
Ettlingen, Germany) for experimental animals.  The anesthetized animals were
positioned headfirst and prone in the scanner within the linear Bruker receive-only
birdcage radio frequency coil (RF coil).  RF coils with three different inner diameters
were used: 56 mm (for imaging of rat aortas), 38 mm (for mouse aorta), and 23 mm
(for mouse cerebral vasculature).
4.3.1  Imaging of mice
In Study I, we performed optimization of the imaging protocol for the mouse
aorta and cerebral arteries by systematically varying the imaging parameters (TR,
TE, PA).  The final protocol was the following:
 For the aortic arch, we first obtained images in an axial plane using GEFC
(Gradient echo imaging sequence, comprising 1st order flow compensation)
sequence with the following parameters: repetition time (TR) 1000 ms; echo time
(TE) 4.0 ms; bandwidth (BW) 101.01 kHz; pulse angle (PA) 90?; frequency x phase
matrix 256 x 192; field of view (FOV) 3.0 cm and section thickness 1.0 mm (in-plane
resolution 117 x 156 µm).  Using these axial images for planning, double oblique
images in a parallel plane to the aortic arch were obtained using the following pulse
sequences: GEFC, RARE (Rapid acquisition with relaxation enhancement), and IR-
RARE (RARE with inversion recovery).  The imaging parameters for the GEFC
images were TR 25.0 ms; TE 6.9 ms; BW 505.051 kHz; PA 30?; frequency x phase
matrix 512 x 512; FOV 3.5 cm and section thickness 1.0 mm (in-plane resolution 68 x
68 µm).  The imaging parameters for the RARE images were TR 5247 ms; effective
TE (TEEF) 20 ms; BW 101.01 kHz; echo train length (ETL) 16; frequency x phase
matrix 256 x 256; FOV 3.0 cm and section thickness 1.5 mm (in-plane resolution 117
x 117 µm).  The imaging parameters for the IR-RARE images were TR 5000 ms;
TEEF 4.2 ms; BW 101.01 kHz; ETL 8; frequency x phase matrix 192 x 192; FOV 3.0
cm and section thickness 1.5 mm (in-plane resolution 156 x 156 µm).  An IR delay of
312 ms was used to suppress the surrounding tissues.
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For the descending thoracic aorta, GEFC images were obtained in an axial
plane with the following parameters:  TR 25.0 ms; TE 4.2 ms; BW 101.01 kHz; PA
30?; frequency x phase matrix 256 x 256; FOV 3.5 cm and section thickness 1.0 mm
(in-plane resolution 137 x 137 µm).  Subsequently, GEFC images were taken in a
nearly sagittal plane, perpendicular to the aortic arch, by using the following
parameters: TR 25.0 ms; TE 4.2 ms; BW 101.01 kHz; PA 15?; frequency x phase
matrix 192 x 192; FOV 3.0 cm and section thickness 1.0 mm (in-plane resolution 156
x 156 µm).
For the upper abdominal aorta behind the liver, GEFC images were taken
in a nearly sagittal plane by using the following parameters: TR 25.0 ms; TE 4.2 ms;
BW 101.01 kHz; PA 60?; frequency x phase matrix 192 x 192; FOV 3.0 cm and
section thickness 1.0 mm (in-plane resolution 156 x 156 µm).
For the abdominal aorta, axial GEFC images ranging from the diaphragm to
the iliac bifurcation were taken with the same parameters as for the aortic arch.  IR-
RARE images in the coronal plane were also taken with the same parameters as for
the aortic arch.
The diameter of the aorta was measured from the MR images of all the
obtained sequences at specific anatomic locations, e.g. aortic root.
For three-dimensional cerebral artery angiograms, time-of-flight (TOF)
pulse sequence with magnetization transfer (MT) was used with the following
parameters: TR 41.0 ms; TE 4.0 ms; BW 101.01 kHz; frequency x phase matrix 192
x 192 x 96; FOV 1.4 x 1.4 x 0.9 mm (spatial resolution 73 x 73 x 94 µm). MT
parameters were: amplitude 5.9 ?T; offset irradiation 2500 Hz and pulse length 25
ms.  The angiograms were reconstructed with maximum intensity projections (MIPs).
Both reconstructed images and raw data were used for evaluation.
4.3.2 Imaging of rats
In Study III we, determined the optimal protocol for the imaging of coiled
(and noncoiled) rat aneurysms, which was later used in Study IV.  Optimization of the
TOF-MRA was done in a simulation-based manner by first making a theoretical
simulation, and then finding the optimal values for imaging by varying the imaging
parameters (TE, TR, PA) within the rational range obtained from the simulation.
The theoretical simulation was based on the T1, T2, and T2* relaxation
times measured for the regions of interest (aneurysm, aorta) and for the surrounding
tissues (fat, muscle).  The simulation revealed the theoretically optimal TR and TE
parameters for achieving maximal aneurysm-to-background contrast.  The
theoretically optimal pulse angle (PA) was calculated by using the Earnst angle
equation.  Signal intensity was measured from the acquired images in order to
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calculate true contrast and the contrast-to-noise ratio (CNR).  The theoretical contrast
and measured true contrast were compared.
Because of the influence of noise, the image with the highest contrast is not
necessarily optimal for the evaluation of anatomical structures (like aneurysm neck
remnant).  We therefore introduced another parameter, the CNR, to objectively
assess the appearance and representativeness of the images.  CNR can only be
measured from actual images, since noise cannot be simulated.  We also rated all
images subjectively by two observers on how well the entire aneurysm neck remnant
could be visualized.
To be able to measure the volume of the neck remnant with TOF-MRA, we
determined that the voxel size should be less than 150 µm.  This would result in an
average in-plane resolution of 13 x 13 pixels in a neck remnant with an initial length
and width of  2 x 2 mm.  To achieve this goal, we used a phase x frequency matrix of
256 x 256 and FOV 3.0 x 3.0 cm, giving us a resolution of 117 x 117 µm.  During the
optimization we used a slice-encoding matrix of 16, which was zero filled to 256.
This was done to reduce acquisition time to 8.11 min.  Acquisition time was kept
constant by increasing or reducing the number of averages (NEX) whenever TR was
changed. Later, the acquisition time was changed to 54.36 min and the voxel was
made isotropic (117 µm) by changing the matrix to 256 x 256 x 128 and the FOV to
3.0 x 3.0 x 1.5 cm. The shortest possible TE allowed by the imaging software was 6.6
ms for the chosen 256 x 256 matrix.  The effects of fat suppression and
magnetization transfer (MT), which suppress tissues that contain protein (e.g. muscle
tissue), were also evaluated.
Measurement of relaxation times for simulation:
For determination of T2-relaxation time a multi-spin multi-echo (MSME)
sequence, based on CPMG (Carr-Purcell Meiboom-Gill) spin echoes  was used.  TR
1500 ms; TE 10-160 ms and 16 echoes; number of averages (NEX) 2; phase x
frequency matrix 256 x 192; FOV 60 x 60 mm; single slice with slice thickness  2.0
mm; acquisition time 7 min 12 s.
For determination of T1-relaxation time, a fast spin-echo saturation-recovery
sequence was used.  TR 101, 282, 503, 787, 1185, 1856 and 5000 ms; TEEF 24 ms;
RARE factor 4; NEX 2; phase x frequency matrix 128 x 128; FOV 60 x 60 mm; single
slice with slice thickness 2.0 mm; acquisition time  10 min 21 s.
For determination of T2* relaxation time, a multiple gradient echo sequence
(MGE) was used.  TR 1500 ms; TE 4.5 – 81.7 ms and 12 echoes; NEX 1, phase x
frequency matrix 256 x 192; FOV 60 x 60 mm; single slice with slice thickness 2.0
mm; acquisition time 4 min 48 s.
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Theoretical simulation:
It is possible to model moving blood approximately as a tissue having
shorter T1,  the T1 shortening dependent on the velocity of blood flow. This effective
T1, denoted by T1,eff, is shorter when blood flow velocity is higher, as more of the
imaging volume is refreshed by “unsaturated” spins. With slow flow, T1,eff approaches
T1 of stagnant blood. TOF contrast was simulated using the equation for gradient
echo signal as follows:
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where ? is the flip angle. The flip angle yielding a maximum signal in a gradient echo
sequence for a tissue with relaxation time T1 is given by the Ernst angle equation:
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where ?E is the Ernst angle.
In the simulations, signal was normalized with TR to simulate varying TR
while keeping imaging time constant (this operation implies continuity of number of
excitations). Setting ? = ?E,blood, we have for the normalized gradient echo TOF signal
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where ? ? ? ?effTTRbloodEbloodE eTR ,1arccos,, ?????  or the Ernst angle for flowing blood as a
function of TR. This equation was used to simulate signal and contrast. The contrast
was studied using difference curves calculated by subtracting background signal from
blood signal. The effect of noise was omitted in the simulations.
The contrast (C) between two (1 and 2) tissues was calculated as:
C1=(S1-S2) / S1,
where S is measured signal intensity from region of interest (ROI), measured with
Paravision 3.0 software (Bruker?, Ettlingen, Germany).  The contrasts between the
aorta, aneurysm neck remnant, fat tissue, and muscle tissue were calculated
separately.
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CNR was calculated as:
CNR = (S1-SA) / ?SA ,
where ?SA is the standard deviation from the signal of the aorta.  Standard deviation
of an area outside the animal could not be measured since it was not included in the
field of view (FOV).  The standard deviation from a structurally and chemically
homogeneous tissue, like the aorta, has earlier been used as an estimate for the
noise (Prince et al. 1994).
The final imaging protocol for the rat aneurysm was the following:
Scout images were acquired in three directions, after which axial RARE
images were obtained using the following parameters:  Time to repetition (TR)
6103.2 ms; TEEF 38.6 ms; ETL 16; BW 100.0 kHz; phase x frequency matrix 256 x
256; FOV 5.0 cm (in-plane resolution 195 x 195 µm) and section thickness 2.0 mm.
The aneurysm was identified from these images and the sagittal sections were fitted
so that they spanned the entire width of the aneurysm and the abdominal aorta.
Using these sagittal images for planning, near-axial images, in the direction of the
aneurysm, were obtained.  Both sagittal and axial images were acquired using GEFC
and RARE sequences.  For RARE images, we used the following parameters: TR
6103.2 ms; TEEF 38.6 ms; ETL 16; BW 100.0 kHz; phase x frequency matrix 256 x
256; FOV 3.5 cm (in-plane resolution 137 x 137 µm) and section thickness 2.0 mm.
For GEFC images, we used the following parameters: TR 1000 ms; TE 4.0 ms; Pulse
angle (PA) 90°; BW 100.0 kHz; phase x frequency matrix 256 x 256; FOV 3.5 cm (in-
plane resolution 137 x 137 µm) and section thickness 2.0 mm.
The optimal TOF-MRA had the following parameters: TR 60 ms; TE 6.6 ms;
PA 20°; BW 25.0 kHz; phase x frequency x slice matrix 256 x 256 x 128; FOV 3.0 x
3.0 x 1.5 cm (yielding a resolution of 117 x 117 x 117 µm).  The optimization
procedure for the 3D TOF-MRA is described in the results section.
4.3.3  Analysis of image data
The signal intensity from specific regions of interest was measured with
Paravision 3.0 (Bruker, Germany).
Neck remnant volume was measured from the raw data of the 3D TOF-
MRA using Image/J public domain software (developed at the U.S. National Institutes
of Health and available on the Internet at http://rsb.info.nih.gov/ij/ ).  First, the
surrounding tissues were manually cropped.  The image was then thresholded using
the aortic diameter as a standard size reference, but taking to account its growth
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during the follow-up.  Groups were compared using independent samples t-test.
Changes within a group were compared using Paired t-test.
The presence of dog ears was evaluated from both the 3D TOF-MRA and
the GEFC images, which were sensitive to flowing blood.  Groups were compared
using the Fisher’s exact test.
The RARE images were used to verify that the surrounding structures (i.e.
the bowels) were not affecting the results.
4.4  Tissue preparation and histological analysis
In Study I, the tissues were perfusion-fixed with 3% phosphate-buffered
paraformaldehyde (3% PFA) through cannulated left ventricles at a 140 mm Hg
pressure.  The aortas and hearts were removed entirely en block to the level of the
iliac bifurcation.  Brains with cerebral arteries were carefully removed via a
craniotomy.  Tissues were kept in 3% PFA for 6 h at room temperature and stored in
PBS at +4°C until the time of paraffin-embedding.  Axial and longitudinal cross-
sections (5 µm) of entire aorta and axial cross-sections of brains with cerebral
arteries were stained with Masson´s trichrome for detection of fibrillar collagens.  For
measurements of cerebral artery wall thickness, the internal carotid arteries were
identified and serial cross-sections were taken from a location immediately proximal
to the origin of the middle cerebral arteries.  The area of the medial layer was
measured from six separate cross-sections from each animal using a computer-
assisted image analysis program (Image/J, U.S. National Institutes of Health).  An
average for each animal was calculated, and the values were compared between
Col-Int? and control mice (t-test).  The total number of spindle-shaped cells in the
medial layer was counted from six separate cross-sections from each animal.
In Study II, the rats were perfusion-fixed through cannulated left ventricles
with 3% paraformaldehyde followed by 6 h of incubation in 3% paraformaldehyde
and paraffin-embedding. The samples were sectioned along the long axis of the
aneurysm at 4-µm intervals and stained with hematoxylin and eosin.
Immunohistochemistry was performed after deparaffinization and antigen retrieval in
heated citrate buffer (pH 6.0) or heated Tris-ethylenediaminetetraacetic acid (pH 8.0–
9.0) buffer. Monoclonal mouse antibodies were used to detect aSMA (clone 1A4,
Sigma- Aldrich Co., St. Louis, MO, USA), anti-rat CD68 (clone ED1, Serotec, Oxford,
UK), and CD3 (T-cell receptor, clone PC3/188A, Dako, Glostrup, Denmark).
Terminal deoxynucleotidyl transferase biotin-dUTP nick end labeling reactions to
detect apoptotic cells were performed with an InSituCell Death detection kit (Roche-
Diagnostics, Roche, Basel, Switzerland).
In Studies III and IV, the tissues were perfusion-fixed with 10% formalin
(phosphate-buffered to pH 7.0) through cannulated left ventricles.  Tissue samples
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were embedded in paraffin.  Primary 1000-µm-thick sections were cut along the long
axis of the aneurysm using an Isomet low-speed saw (Buehler, Lake Bluff, IL, USA)
cutting through the platinum coils (Dai et al. 2005).  After this, the coil loops were
carefully removed with forceps. The final 5-µm-thick slices were then cut and stained
with hematoxylin and eosin.  Inflammatory cell infiltration and scar forming were
evaluated.  Measurements of neck tissue thickness were not performed since it was
impossible to ensure that the histological sections were always taken from the same
location.
4.5  Endoscopy
In Studies III and IV, the animals were sacrificed and the aneurysms were
harvested immediately after the last imaging session (in Study IV on the 28th day).
Before giving a lethal dose of the anesthetics, an inspection was made through
laparotomy, to ensure that the aneurysm had not adhered to surrounding structures
(i.e. the bowels), and to verify that the aneurysm was pulsating.  The posterior wall of
the aorta was gently opened with iris scissors, and the lumen of the aneurysm neck
was inspected using a Storz (Karl Storz GmbH, Tuttlingen, Germany) endoscope,
connected to a digital video camera (Sony Exwave? HAD SSC-DC58AP, Japan).
The first aim of the endoscopic examination was to verify that the anastomosis had
been made correctly.  The second aim was to see whether the lumen of the neck
remnant also contained dog ears protruding between the coils and the aneurysm
wall.  The third aim was to evaluate the transparency of the endothelial-like neointima
over the coils.  The live image was evaluated by two observers, but also recorded for
later viewing.  The results from endoscopy were compared with the MR images.
4.6  Statistics
Statistical analysis was performed by using NCSS 2000 (NCSS, Kaysville,
UT, USA) statistics software.  The level of significance was set at p <0.05.
Categorical variables were compared using Fisher’s exact two-tailed test or Chi-
square test.  Continuous variables between groups were compared using the Mann-
Whitney U-test or Student’s t-test.
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5.  Results
5.1  Optimization of MRI for the aorta and cerebral arteries of mice
We imaged five Col-Int? mice and five age- and weight-matched control
mice at the age of 16 months.  We were able to obtain high-resolution MR images in
three imaging planes (axial, sagittal, coronal) of the entire aorta, including the origin
of the ascending aorta, without significant motion artifacts, even without pulse- and
breath-triggering.  Triggering would have multiplied the total acquisition time for the
thoracic aorta, but with adequate fixation of the animals chest to the cradle with
adhesive tape, we were able to eliminate thoracic motion during thoracic imaging.
Similarly, for abdominal imaging, abdominal motion was eliminated by firm fixation of
the lower body.  The highest in-plane resolution of 68 x 68 µm was achieved with a
GEFC sequence using a 1.0-mm slice thickness in a sagittal imaging plane of the
thoracic aorta and an acquisition time of 8.32 min.  For RARE and IR-RARE images,
the maximum in-plane resolution varied from 117 x 117 to 156 x 156 µm with 1.5-mm
slice thicknesses, and the acquisition times varied from 4.11 to 8.30 min.  Intraluminal
flow was primarily evaluated from the IR-RARE images, the GEFC images were the
best to show the aortic root, and the RARE images were the best to show
extravascular structures.  All of the sequences in the plane of the aortic arch showed
less motion artifacts than the GEFC sequences taken sagittally or axially to the
descending aorta.
After optimizing 3D TOF-MRA, we achieved a resolution of 73 x 73 x 94
µm, using an acquisition time of 51 min.  This was sufficient to visualize the entire
circle  of  Willis  and  the  distal  branches  of  the  cerebral  arteries  up  to  level  of  the
anterior cerebral arteries (Figure 4).  MRI of cerebral arteries was completed with four
Col-Int? mice, while one mouse died during the acquisition.
To verify the imaging results, we immediately performed microsurgical
dissection of the entire aorta, removed the brains through a craniotomy, and
processed the tissues histologically.
5.2  Appearance of Col-Int? mice aortas and cerebral arteries in MRI
and histology
Aortas of all Col-Int? mice appeared to be normal in MRI.  There were no
signs of aortic dilatation or aneurysm formation, and the mean diameter of the aortas
measured from MR images at specific levels showed no difference between Col-Int?
mice and controls (e.g. aortic root measured from GEFC sequence: Col-Int? 1.41 ?
0.023 mm vs. control 1.41 ? 0.071 mm; p=0.97).  All MR images were also screened
for narrowing of the lumen and for signs of previous rupture or aortic dissection,
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which would have presumably appeared as a thickening of the aortic wall with
laminar organization of hematomas of various ages or a parathoracic or
retroperitoneal hematoma.  None of these signs were seen in any of the Col-Int? or
control mice.
Inspection of the aortas and surrounding tissues under a stereomicroscope
was concordant with the MR images; no abnormalities suggesting aneurysms,
dissections, or previous ruptures were seen, and the external aortic diameters in Col-
Int? mice were similar to the diameters in control mice.  Qualitative analysis from
histologic samples showed no microaneurysms or dissections in the aortic wall.
With the resolution achieved, also the cerebral arteries appeared normal
and there were no signs of aneurysms.  However, histologic analysis revealed that
the cerebral artery wall was 22% thinner in Col-Int? mice than in controls (p=0.01, t-
test), but the numbers of spindle-shaped cells were similar in Col-Int? and control
mice (p=0.97, t-test), suggesting that the thinning was related to decreased
extracellular matrix protein (collagen) content rather than to cellular content (Figure
4).
Figure 4:
TOF-MRA reconstruction of the cerebral arteries of Col-Int? mice (a,b). Photograph showing
histological sections of cerebral arteries of Col-Int? (c) and control (d) mice. Cerebral arteries labelled
in (a): basilar artery (arrowhead), basilar bifurcation (open arrow), superior cerebellar artery (open
arrowhead), internal carotid artery (two arrowheads), posterior cerebral artery (arrow), distal branches
of middle cerebral arteries (two arrows), pericallosal branches of anterior cerebral arteries (three
arrows). In c and d the arrows point at the adventitial layer.
dc
ba
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5.3  Experimental aneurysm model in rats
We established an experimental aneurysm model in rats by transplanting a
segment of the descending thoracic aorta of a donor animal into the abdominal aorta
of the recipient.  The aneurysm model is easy to standardize, the patency of the
aneurysms is excellent, and the mortality is low.  We constructed a total of 112
experimental aneurysms in rats.  Seven procedure-related deaths occurred, of which
three happened in aneurysms being simultaneously coiled.  The deaths were caused
by profuse bleeding (n=3), aortic thrombosis (n=3), and an overdose of anesthetics
(n=1).  The overall mortality was 6.3% (4.7% for aneurysm construction alone, 11.5%
for coiling procedure).  All procedure-related deaths occurred within 24 h of the
operation, and all in the first 30 operations.  The high mortality associated with the
coiling procedure (3/26 =11.5%) was due to three fatal cases during the six training
operations.  Native aneurysms (n=79) were followed up for a median of 6 weeks
(range 3 days – 2 years).  During this time, two animals died of unknown causes.
Primary thrombosis of the aneurysm seen in the MR images on the first day occurred
in two cases (2/79 = 2.5%) and early thrombosis seen in the MR images during the
first 10 days occurred in four cases (4/79 = 5%).  The overall patency of the
aneurysms was therefore 92.5%.  Three aneurysms enlarged during follow-up, and
the rest remained the same size (measured from 2D MR images).  In Study IV, all
animals (n=20) survived the operation and coiling procedures, but four animals,
exhibited primary thrombosis of the aneurysm (4/20 = 20%).  As with naive
aneurysms, the primary thrombosis was caused by an improperly placed suture or
improper alignment of the graft and parent-artery walls, seen in endoscopy.  In naive
aneurysms, the primary thrombosis could also be caused by applying pressure to a
leak from the anastomosis (n=2).  The higher rate of primary thrombosis in coiled
aneurysms is explained by the suturing being more technically demanding when
coiling has been performed.  The success rate of 80% can still be considered to be
good.  The mean procedure time for creating the aneurysm was 41 (range 24-61)
min.  Coiling prolonged the procedure by 20 (range 16-28) min.  The length of the
aneurysms in the long-term follow-up was easy to standardize (4.2 ? 0.3 mm).
Moreover, the volume of the initial neck remnant in coiled aneurysms did not vary
significantly (6.35 ? 1.58 mm3).
The graft can be transplanted into two locations in the abdominal aorta,
either superiorly or inferiorly to the lumbar vein.  After the preliminary experiments,
we found the superior location (directly distal to the renal arteries) preferable since
this location is less susceptible to complications.  Complications arise because the
adventitia of the aorta and the inferior vena cava are more closely attached to each
other, resulting in an easy tearing of the vena cava, causing hemorrhage.  Moreover,
in the preferred superior location, the aortic diameter is larger and there is usually
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only one arterial branch arising from this site.  This branch going to the back muscles
can be ligated without any complications, and this should be done to avoid retrograde
bleeding, which seriously interferes with proper anastomosis suturing.  Repeated
flushing with heparinized saline is recommended if there are any signs of bleeding
from the arteriotomy of the unfinished anastomosis, e.g. because of slippage of the
vascular clamps.  If there is severe bleeding from the anastomosis after opening the
vascular clamps, additional stitches can be applied either with or without temporary
clamping of the vessel.  If temporary clamping lasts for many minutes (>5 min), the
patency of the anastomosis may be jeopardized due to accumulation of a thrombus;
opening a part of the anastomosis and rinsing both the recipient artery and the graft
with heparinized saline are advised to avoid primary thrombosis.
Coiling was successful on every occasion in Wistar rats weighing more than
350 g.  In larger rats, the coiling procedure was easier because of the larger arterial
diameter.  In rats weighing less than 350 g, it was impossible to fit even the smallest
GDC coils (diameter 2 mm) since they would not produce loops.
In Study IV, we created 20 standard-sized aneurysms, half of which were
coiled with platinum coils and half with PGLA-coated coils and all of which possessed
an approximately 2-mm-long neck remnant at surgery.  There was no difference in
the procedure time (coiling and suturing of anastomosis) between the two groups
(mean: PGLA group 88 min,  platinum group 86 min).  The aneurysms did not differ in
orientation.  At the end of the follow-up, no aneurysm had adhered to the bowels.
Sixteen animals exhibited a visible neck remnant on day 1, and these were included
in the radiological evaluation and followed up.  The remaining four animals (PGLA
group n=1, platinum group n=3) were in good clinical condition, but exhibited
complete initial thrombosis of the neck remnant.  Although not included in the
radiological evaluation, follow-up imaging of these thrombosed aneurysms was
performed, but no recanalization was found.  The endoscopic analysis at 4 weeks
revealed that the thrombosis was caused by an improperly placed suture (n=2) or
improper alignment of the graft and parent-artery walls (n=2).  In conclusion, possible
thrombosis of the graft caused by improper suturing of the anastomosis should be
ruled out, by MRI at the first and seventh day after the procedure.  If the aneurysm
neck is patent at 1 week, it is reliable to begin follow-up of the interface of the coils
and the aneurysm.
We have also conducted preliminary experiments using expandable nitinol
stents.  The stent causes an artifact inside the lumen of the vessel, but the aneurysm
can be adequately evaluated.  In the future, the model can be used to test flow-
directing or porous stents developed for aneurysm treatment without additional
coiling.
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5.4  Histological changes in the rat aneurysm model
The histological changes in the murine experimental aneurysm wall were
described in detail in Study II and have also been discussed in the thesis of Dr
Juhana Frösen (2006c).  The saccular aneurysms develop several histological
changes that are characteristic of human SCAAs.  These include: a) de-
endothelialization, b) luminal thrombosis, c) organization of the luminal thrombosis
and formation of neointima (myointimal hyperplasia), and d) inflammatory cell
infiltration.  However changes such as decellularization and degradation, which are
found in ruptured human SCAAs do not occur in the murine model.
On day 3 a monolayer of endothelial-like cells (?SMA-negative) lined the
luminal surface of the aneurysm fundus.  At 3 weeks, a neointima had formed on the
luminal side; this layer contained areas of organizing thrombus.  At 3 months, the
neointima had become thicker and capillaries were found in it in all samples (7/7).
Inflammatory cells were seen at all time-points.  At 3 days these consisted mostly of
macrophages (CD68+) in the media and adventitia.  From 3 weeks onwards
macrophages were also found in the newly formed neointima, along with T-
lymphocytes (CD3+).  The neutrophils originally present in the adventitia had
disappeared by 3 weeks.  Apoptotic cells (TUNEL staining) were found in the media,
and at 3 months also in the neointima.
Even though very different pathobiological mechanisms cause the
histological changes in the wall of human SCAAs and the wall of the experimental rat
aneurysm, there are many similarities in the end result, as described above.  This
leads us to believe that this model is suitable for studying thrombus formation and
inflammatory cell infiltration after endovascular treatment.  For histology of coiled
aneurysms, see the section entitled: Occlusion of the neck remnant after treatment
with platinum-, or PGLA-coated coils.
5.5  MRI of rat aneurysms
We were able to follow up the patency of the saccular aortic grafts with 4.7
T MRI.  2D MR images (GEFC and RARE) reliably showed the width, length, and
shape of the aneurysm  and neck remnant.  From these images, it was also possible
to detect thrombosis, verify parent artery integrity, and observe relation of the
aneurysm to the surrounding structures and in this way exclude adhesion to
intestines.  The 3D TOF-MRA sequence was optimized for the measurement of neck
remnant volume.  In the coiled aneurysms, radiological signs of healing
(disappearance of dog ears) could be seen with both 2D and 3D sequences.
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One complete imaging session lasted 2 h per animal; during this time TOF-
MRA was performed and GEFC and RARE images were taken in both axial and
sagittal planes.  3D TOF-MRA was the most time-consuming, acquired in 32 min 40
s. The isotropic voxel size was 117 µm in the TOF-MRA.  In the other sequences, the
in-plane resolution was 137 x 137 µm, and the section thickness 2 mm.
During a total of 271 MRI sessions only one death occurred, yielding a
mortality rate of 0.37%.   Artifacts interfering with interpretation were seen in less
than 1% of all images and the acquisition was repeated in these cases.
5.5.1 Optimization of TOF-MRI for coiled rat aneurysms and concordance with
measurements
We successfully performed optimization of TOF-MRA in a simulation-based
manner.  By first measuring the relaxation times from the regions of interest
(aneurysm and aorta) and from the surrounding tissues (intraperitoneal fat and spine
musculature), a theoretical simulation was performed that gave maximal signal
intensity and contrast between tissues as a function of TR and TE (Figure 5).  We
then performed imaging by systematically varying the TR and TE within the rational
range of values depicted by the simulation.  After imaging five animals, we measured
signal intensity and calculated contrast and found that the TR and TE giving the
highest values were concordant with the simulation (Figure 5).
The theoretically optimal pulse angle (PA) was calculated with the Earnst
angle equation.  During imaging the PA was varied from 10° to 50° at 10° intervals
independently for different TR, TE, and mode of background suppression.  The
highest contrast was acquired with PA values near the theoretically optimal values.
The good correlation between the simulation and the acquired images improves the
validity of the following results.
Figure 5:
Results of the simulation showing aneurysm-to-background contrast as a function of TR and TE (A).
Figure B shows the agreement between simulation (line) and measurements (dots). In the simulation,
aneurysm-to-background contrast is highest at TE 16.3 ms, for any given TR.
A B
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5.5.2  Achieving optimal imaging parameters
Effect of echo time (TE)
According to simulation, TE = 15.3 - 16.3 ms gave the highest contrast to
background for both aorta and aneurysm at any given TR.  We tested TE values
ranging from 6.6 to 65 ms and found that contrast of aorta-to-background increases
until 20 ms.  Aneurysm-to-background contrast is highest at 10 ms.  The correlation
between simulation and imaging results is good.  The center of the aneurysm (from
where relaxation time is measured) is visible at all TE values, except 65 ms.
However, with TE ?10 ms, the turbulent and slow flow at the edge of the aneurysm is
no longer visible (n=5/5), and the volume measurement is not reliable.  The contrast-
to-noise ratio from the entire aneurysm (center and edge) is highest at the shortest
possible TE (6.6 ms).  The optimal TE is therefore considered to be 6.6 ms.
Effect of repetition time (TR)
TR values ranging from 20 to 125 ms were tested, but the use of a TR
value shorter than 30 ms required the use of a more robust matrix (128 x 256), which
also reduced the resolution.  The simulated and obtained aneurysm-to-background
contrasts for different TRs differ in that simulation gives the highest contrast for the
shortest possible TR, but measurements show that contrast does not increase further
for TR values shorter than 30 ms.  The CNR is higher for shorter TR.  A TR of 30 ms
was considered to be the best, but a problem occurred when making the voxel
isotropic and the acquisition time longer since our scanner overheated.  However,
because images with TRs of 30 and 60 ms were both good for interpretation, we
continued by using a TR of 60 ms as the longer TR did not cause overheating.
Effect of pulse angle (PA)
With the smallest PA (10°), the signal from the aneurysm is almost equal to
the signal from the aorta and the contrast to the background is high.  With higher PA,
the background becomes suppressed, but also the signal from the aneurysm starts to
decay, as the signal from fast-flowing blood in the aorta is intensified, suggesting the
use of short PAs.  CNR is highest for TR 60 ms at PA 20° and for TR 30 ms at PA
10°.  These angels were considered optimal and correlated well to the theoretically
optimal PA derived from the Earnst angle equation (19° for TR 60 ms and 14° for TR
30 ms).  The changes in contrast and CNR are independent from the effects of TE,
fat suppression, and magnetization transfer.  Figure 6 shows the change of aneurysm
signal for different PA and modes of background suppression.
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Effect  of background suppression
With the use of fat suppression and magnetization transfer, the signals from
the aorta and aneurysm become more intense relative to fat and muscle tissue.
However, when using background suppression, there is also a small signal loss from
the aneurysm compared with the aorta, at tested PA, TR, and TE.  We conclude that
the images with suppression are all as valid for interpretation as the images without
suppression, but the small loss of signal favors no background suppression.  The
maximum intensity projections (MIPs) are better with background suppression, but
the raw data is used for the volume measurement.
Figure 6:
The use of fat suppression or magnetization transfer results in reduced aneurysm to aorta contrast.
This is also seen with increasing PA. Aorta (arrow), Neck (arrowhead), Coil (open arrowhead).
True high-resolution image
The in-plane resolution of 117 x 117 µm was achieved by choosing a phase
x frequency matrix of 256 x 256 and a FOV of 3.0 x 3.0 cm.  With a more robust
matrix, we would not have been able to detect changes in the aneurysm neck
sufficiently well.  During the optimization we used a slice-encoding matrix of 16,
which was zero filled to 256, in order to reduce acquisition time to 8.11 min.  After the
optimization, we repeated imaging with TR/TE/PA (60/6.6/20) and changed the
acquisition time to 54.36 min and made the voxel isotropic (117 µm) by changing the
matrix to 256 x 256 x 128 and FOV to  3.0 x 3.0 x 1.5 cm.  This resulted in a true
high-resolution (117 x 117 x 117 µm) image (Figure 7).  The average volume
obtained from imaging was 6.28 ? 1.52 mm3 (n = 5,  mean ± SD).   Figure 8 shows
how results from histological sections, endoscopy, and MRI correlate with each other.
PA   20                 30                 40
Magnetization transfer -
Fat suppression -
Magnetization transfer -
Fat suppression +
Magnetization transfer +
Fat suppression +
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TR 60 ms was used instead of 30 ms because short TR increased the risk
for overheating of the MR scanner, which resulted in the need to abort acquisition.
The interpretability of images with TR 60 ms was equal to that with TR 30 ms, despite
a slightly lower CNR.
Figure 7:
3D-reformatted TOF MRA images showing in right lateral (a), superior (b),  and left lateral (c) view.
Raw data of 3D TOF used for volumetry (d-f).
Figure 8:
Correlation between endoscopy, histology (HE-stain) and TOF-MRA immediately prior to harvesting.
The morphology of the neck remnant (N) matches the shape seen in histology and endoscopy.
A=Aorta, N=Neck remnant, * =Coils, Arrowhead=Open dog ear.
* *
A A
NN
2.5mm
Coil
Recanalization
Aorta
Neck
a b c
d e f
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5.6  Occlusion of neck remnant after treatment with platinum or
PGLA coated coils
The use of PGLA-coated coils resulted in an improved angiographic
outcome, seen as disappearance of dog ears during follow-up (in 2D and 3D images)
and a moderate progressive reduction of neck remnant size in volumetric analysis.  In
the endoscopic evaluation, the PGLA group exhibited a neointima which appeared
thicker.  Moreover, in histological analysis, thrombus organization and inflammatory
cell infiltration were higher with PGLA.
5.6.1 Neck remnant analysis
At the beginning of follow-up, most aneurysms possessed visible dog ears
in addition to the larger neck remnant (PGLA group 66.7% (n=6/9), and platinum
group 71.4% (n=5/7)).  Dog ears were defined as small blood-filled cavities, that
protrude between the coil mass and the aneurysm wall in the distal part of the neck
remnant.  These can be seen with both conventional 2D sequences and 3D TOF-
MRA.
Initially, no statistically significant differences in the presence of dog ears
between the two groups were seen.  However, by day 28, only 11.1% (n=1/9) of the
aneurysms with PGLA-coated coils showed remaining dog ears, whereas all dog
ears in platinum coiled aneurysms had persisted (n=5/7) (p=0.035) (Figure 9).  No
false-positive or -negative dog ears were observed when the 3D-TOF angiograms
taken on day 28 were compared with the endoscopic images.  Thus, the
concordance between MRI and endoscopy was considered to be excellent.
5.6.2 MRI volumetry
There was no difference in the initial size of the aneurysm neck remnants
between the two groups.  Volumetric measurements from the TOF-MRA images of
the 16 animals included for evaluation showed that the size (mean ± SD) was 6.84 ±
1.75 mm3 for the PGLA group and 5.96 ± 1.40 mm3 for the platinum group.  During
the first week an increase in the size of the neck remnant was seen in both groups,
presumably due to hemodynamic stretching.  After the first week, the neck remnant
size in the PGLA group started to decrease, whereas in the platinum group it
remained steady.  By the end of the follow-up, the neck remnants of the PGLA-coiled
aneurysms had reduced in size by 12.9 ± 17.4 % (p=0.044), while the neck remnants
of the platinum-coiled aneurysms had increased by 6.63 ± 22.4 % (p=0.474).  An
increase in neck remnant size was observed in only 1/9 aneurysms in the PGLA
group, whereas it was seen in 5/7 aneurysms in the platinum group (p=0.035).
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5.6.3  Endoscopic analysis
A pale neointima covered the coils in 15/16 aneurysms (94%).  Notably,
one aneurysm with a platinum coil lacked the neointima completely.  In 4/7
aneurysms (57%) in the platinum group, the neointima was translucent, whereas in
the PGLA group 7/9 aneurysms (78%) exhibited such a thick neointima that it was
impossible to see the coil loops through it. These changes were statistically
nonsignificant (p=0.126).
5.6.4  Histological analysis
We found that 4/10 aneurysms in the PGLA group exhibited a dense
fibrosis of the fundus and showed high amounts of inflammatory cell infiltration as
well as growth of new capillaries.  These changes were not seen at all in the platinum
group; instead, in 2/10 aneurysms, only immature thrombosis was present.  The
remaining aneurysms from both groups exhibited intermediate changes consisting of
varying amounts of fibrosis interspersed with areas of unorganized thrombosis
(p=0.043) (Figure 10).
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Figure 9:
Correlation between endoscopy and MRI on day 28. Endoscopic photographs and corresponding MR
images (GEFC sequence) are shown adjacent to each other. A-C: PGLA-coiled aneurysms, notice
smooth dome shape of aneurysm neck. D-F: Platinum coiled aneurysms, notice dog ears (arrows) in
MRI and endoscopy. In the platinum coil group, the neointima is translucent, and coils are visible.
Arrowhead indicates abdominal aorta.
Figure 10:
Histological changes in coiled rat aneurysms. PGLA-coiled aneurysms exhibit  higher inflammatory
cell infiltration and maturation of thrombus and a neointima. Platinum coil is surrounded with an
immature thrombus.
PGLA Platinum
Aorta
Coils
Neck
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6.  Discussion
Our main goals were I) to create a reliable high-resolution MRI protocol for
the imaging of mice with genetic deficiencies predisposing to internal hemorrhage or
spontaneous formation of aneurysms, II) to develop an experimental aneurysm
model in rats, suitable for endovascular treatment, III) to optimize a reliable high-
resolution MRI protocol suitable for repetitive follow-up of endovascularly treated
aneurysms in rats including an optimized high-resolution TOF-MRA sequence
suitable for quantitative volumetric analysis of neck remnants, and IV) to compare the
efficacy of platinum coils with second-generation PGLA-coated coils in the rat model.
6.1  MRI of the mouse vasculature
For the purpose of studying the vasculature of mice, we created a high-
resolution MRI protocol.  The type I collagen-deficient mice (Col-Int? mice) that we
imaged, had been shown to die of bleeding into the thoracic cavity (Rahkonen et al.
2004).  Whether these mice develop a gradually enlarging aneurysm in the thoracic
aorta or whether the aorta is acutely dissected was unknown.  We were able to
acquire images of this specific region of interest (thoracic aorta) with an in-plane
resolution of 68 x 68 µm, using a GEFC sequence.  An in-plane resolution of 100 x
100 µm has earlier been demonstrated to be sufficient to detect local aneurysm-like
protrusions in a mouse model of Marfan’s syndrome (Itskovich et al. 2003).  Most
studies concerning MRI of the mouse aorta have been done in order to detect
atherosclerotic plaques.  In these studies, the in-plane resolution has been similar to
ours: 48 x 48 µm (Fayad et al. 1998), 49 x 98 µm (Weismann et al. 2003), 109 x 109
µm (Choudhury et al. 2002), and 140 x 187 µm (Hockings et al. 2002), although 7.0
or 9.4 T MR scanners have been used and the slice thickness has varied from 187 to
500 µm.  Using a 4.7 T MR scanner, we had to use a thicker slice (1.0-1.5 mm) in
order to get a sufficient amount of signal.  However, this is not a large compromise
since the slice is less than the diameter of the imaged vessel and there is no overlay
of surrounding structures included in the image.
Our imaging protocol was fast since we were not constrained to use pulse-
or breath-triggering.  With proper fixation of the animal to the cradle and changing of
the phase- and frequency-encoding directions, motion-based artifacts interfering with
image interpretation were not seen.  The use of heart- and breath-triggering is in
general beneficial when imaging the body, but it is not necessary when imaging the
abdominal area (Fayad et al. 1998).  We tested heart-triggering with mice and were
able to acquire cinematographic images of the intra-thoracic structures, including the
heart, and measure the wall thickness of the heart chambers.  However, the blood
vessels were rather stabile, and image quality of the aorta was not significantly better
with heart-triggering.  Triggering always prolongs imaging time since the length of the
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cardiac cycle may gradually increase as anesthesia becomes deeper.  Imaging times
are especially long if both heart- and breath-triggering are combined because heart
and breath cycles needs to appear synchronously before acquisition takes place.
Furthermore, with triggering, one is constrained to certain TE and TR values.  The
choice of anesthetic is important, as with isoflurane the animals breath more deeply
and the motion from the diaphragm interferes with interpretation of abdominal
structure (including aneurysm) if triggering is not used.  Therefore, our observations
support the use of heart-rate-lowering Hypnorm® or Ketalar®.  When triggering is
used (e.g. when imaging the heart), continuous isoflurane is better since its
concentration can be adjusted during imaging.  Triggering is not needed in imaging of
the cerebral vasculature.
In cerebral artery imaging, we achieved a resolution of 73 x 73 x 94 µm
using a TOF-MRA sequence with a 50.1-min acquisition time.  There is only one
earlier report concerning TOF-MRA of the cerebral arteries in mice; using a 4.7 T MR
scanner, Beckmann et al. (2000) achieved an inferior resolution of 150 x 100 x 100
µm.  Since the diameter of the M1 segment is approximately 300 µm, it should have
been possible to detect aneurysms at least the size of the parent artery in the typical
proximal locations (ICA, MCA, Acom) with the resolution achieved.  However, the
possibility remains that there are more distal or microaneurysms in the cerebral
arteries of Col-Int? mice.
To verify the results of imaging the aorta and cerebral arteries had to be
harvested immediately.  No false-negative cases emerged, increasing the value of
our imaging protocol.
6.2  Studies in mice with genetic deficiencies predisposing to
vascular defects
6.2.1  Relevance of collagen in the formation of aneurysms
Type I collagen is found in all three layers of the vessel wall and is
responsible for its tensile strength.  It is the predominant protein in the outer layer, the
adventitia, whereas type III collagen predominates in the media (Gay 1978, Miller
1987).  Together these two collagens represent 80-90% of the total arterial wall
collagens (Burke et al. 1977).  A deficiency of type III collagen (Col3a1 mutation)
leads to fatal consequences in patients suffering from the vascular form of Ehlers-
Danlos syndrome, due to aortic rupture (Schwarze et al. 2001).  Defective type I
collagen can sometimes cause aortic dissection in patients suffering from variants of
osteogenesis imperfecta (Ashraf et al. 1993, Mayer et al. 1996, Isotalo et al. 1999).
In the formation of saccular cerebral artery aneurysms in humans, a variety of
hereditary connective tissue disorders have been recognized, the most common of
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which are autosomal dominant polycystic kidney disease (ADPKD) (Schievink et al.
1992), the vascular form of Ehlers-Danlos syndrome  (Schievink et al. 2004),
neurofibromatosis type I (Schievink et al. 1997, Pfohman et al 2001), fibromuscular
dysplasia (Kalyanaraman et al. 1980), and Marfan's syndrome (Pfohman et al. 2001).
Deficiencies of type I collagen may also play a role in the formation of saccular
cerebral artery aneurysms.  Mutations in COL1A2, encoding the ?2(I) chain of type I
collagen, have been shown to contribute to the formation of both familial and
sporadic saccular cerebral artery aneurysms in the Japanese population (Yoneyama
et al. 2004).
6.2.2  Significance of Col-Int? mouse strain for studies of aneurysm formation
The vessels of Col-Int? mice were found to be normal when we imaged
them at the age of 16 months.  An earlier study (Rahkonen et al. 2004) reported a
survival rate of 46% at 18 months.  The lack of aneurysm in MRI and microscopic
inspection supports the theory of an acutely developed dissection.  Although the
animals were imaged only once it would have been exceedingly probable that the at
least one of them would have developed an aneurysm by this age if aneurysm
formation and rupture explain the thoracic hemorrhage seen in this subgroup of mice
The histology of the cerebral arteries of the Col-Int? mice was
characterized for the first time.  The analysis revealed that the cerebral artery wall
was 22% thinner in Col-Int? mice than in controls.  The number of spindle-shaped
cells in the media layer being similar in both Col-Int? and control mice suggests that
the thinning is related to decreased collagen content.  This is in line with previous
results showing that mRNA levels of pro?1 collagen are decreased by 29% at the
age of 2.5 months, decreasing further to 58% by the age of 12 months (Rahkonen et
al. 2004).  The total amount of collagen in the aorta, measured by the hydroxyproline
assay, is decreased by 20% compared with controls.
MRI at 4.7 T is feasible for high-resolution imaging of the aorta and cerebral
arteries of mice.  Based on our findings, the Col-Int? mouse strain does not provide
insight into the formation of saccular aneurysms.  The mechanism causing thoracic
hemorrhage appears to be an acute dissection of the aortic wall rather than a
gradually developing aneurysm.  This model might be beneficial in studies of drugs
used to prevent aortic ruptures caused by a dissection.
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6.3  Experimental aneurysm model in rats
A good experimental aneurysm model should exhibit characteristics similar
to those in human aneurysms.  The aneurysm should grow or remain patent and be
of the same size as human SCAAs in order to be able to compare endovascular
devices.  The model should also be easy to standardize and reproduce and
inexpensive.
A variety of different animal models have been developed to simulate
human SCAAs (see review of literature).  None of these models exhibit all of the
pathobiological features of human SCAAs.  The wide availability of different murine
strains has favored the use of these animals for research over larger mammals.
Different transgenic strains, especially in mice, are good tools for elucidating the
pathological mechanisms involved in different diseases, including aneurysm
pathophysiology.  By inducing hypertension (renal artery ligation) and ligating one
carotid artery in rats and mice it has been possible to produce intracranial aneurysms
(anterior cerebral artery, olfactory artery) that closely resemble human SCAAs in that
they have a thinning of the media, including apoptotic cells and a degenerated
internal elastic lamina.  There are, however, two major limitations in this model.  First,
standardizing the size of the aneurysms is not possible.  In fact, even after 6 months
of hypertension, 17% (6/35) of the animals show no visible aneurysms with light
microscopy, and even the largest aneurysms (31%, 11/35) are only blebs, with a
height of barely more than half of their orifice (Morimoto et al. 2002).  The long
incubation time and numerous animals needed make this model very expensive.  To
compare treated animals with controls, it is necessary to discover and verify the
aneurysm size in vivo at the beginning of treatment and not just postmortem.  Our
high-resolution imaging techniques could be used for this purpose.  The second
limitation of the hypertension model is that treatment would need to be systemic, as
the cerebral vessels in murines are not sufficiently large for catheterization and
embolization with standard equipment.  To overcome this size problem, we placed
the experimental aneurysm in the abdominal aorta and were able to construct
aneurysms of a standard size and equivalent to the small ruptured ones in humans.
Venous pouch models have been developed in swine, dogs, sheep, and
rabbits.  Criticism against the venous pouch models has mostly arisen due to the
finding that these aneurysms contain more inflammatory cell infiltration and exhibit
neointima formation (Cawley et al. 1996, Abruzzo et al. 1998) making the wall thicker
than approximated for human SCAAs according to early autopsy studies (Walker et
al. 1954, Stehbens 1963, Suzuki et al. 1978, Schlote et al. 1994).  Nevertheless, it is
now known that a significant number of both ruptured and especially unruptured
aneurysms in humans do contain intimal thickening and inflammatory cell infiltration
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(Frösen et al. 2004, Tulamo et al. 2006), supporting the use of venous pouch
aneurysms or other surgically created aneurysms.  The venous pouch aneurysms do,
however, spontaneously thrombose (Guglielmi et al. 1994).  In a study by Byrne et al.
(1997), all aneurysms (5/5) were occluded by 2-7 weeks.  This happened also in the
venous pouch model in dogs (Kerber et al. 1977), where 6/30 aneurysms were
occluded before the first examination, at 2-5 weeks.  In addition, the venous pouch
model requires an anastomosis, making the construction more difficult and time-
consuming.  The suture line has been speculated to contribute to the occlusion of the
aneurysm (Cawley et al. 1996).
The advantage of the elastase-induced aneurysm model is that it lacks the
suture line, which can affect the results in surgically created models.  In histological
analysis, the elastase-induced aneurysms have an attenuated media and internal
elastic lamina, but the lack of inflammatory cells is a major difference compared with
human SCAAs.
The problem with standardization of aneurysm size is common to most
models.  In the best swine jugular vein model to date (Byrne et al. 1997), aneurysms
varied between 10 and 14 mm in length and between 5 and 6 mm in width.  Still this
is a 40% difference in size, twice as much as in our model.  The elastase-induced
aneurysms in rabbits have shown even larger size variation, with the length ranging
between 2.6 and 12.5 mm (Ding et al. 2006).  Similar substantial differences have
been reported in other elastase-induced models, e.g. 4.3–10.8 mm  by Hoh et al.
(2004).
Our experimental aneurysm model in rats is reliable and suitable for trials
comparing endovascular devices since the patency is good and the aneurysms are of
standard size.  The low mortality and complication rates and low costs of acquiring
make the total costs of the model very low compared with other models.
The largest disadvantage with our aneurysm model is its rather small size.
Although comparable with small ruptured SCAAs in humans, the model enables the
use of only the smallest coils.  It is not possible to simulate giant aneurysms, where
the large coil-mass is more susceptible to significant compaction.  However, in our
model, coiling is performed using a predetermined number of coils, allowing a
standard-sized neck remnant. Experimental and clinical studies have shown a clear
correlation between packing density (occlusion rate) and recurrence.  When the initial
outcome of coiling is standardized, the result is not dependent on packing density,
and therefore, only the actual characteristics of the coil are tested in our model.
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6.4  Use of MRI for follow-up of experimental aneurysms in rats and
mice
We proved that MRI is suitable for the follow-up of experimental aneurysms
in rats and mice.  The images are of good quality and interpretation is reliable.  The
use of perpendicular imaging planes enables the evaluation of the aneurysm or neck
remnant from different directions.  The most accurate view of an aneurysm and neck
remnant is gained with the TOF-MRA sequence, which also enables quantification of
the volume because of its high resolution (discussed in the next section).  Because
MR imaging is noninvasive and rather quick, all animals can be imaged repetitively
and the evolution of the aneurysm (recanalization vs. gradual occlusion) can be
followed.  Inability to obtain images was very rare, and acquisition could be repeated,
if for instance, motion-based artifacts were seen.  In our  series, only one death
occurred over the course of 271 imaging sessions (0.37%).  Images of the abdominal
aorta are of high quality, even without the use of heart- and breath-triggering,
particularly when ketamine instead of isoflurane is used as the main anesthetic.
One limitation of the MRI protocol is that the abdomen cannot be imaged if
the rat weighs more than 600 g, since the rat will not fit into the RF coil of our system.
Imaging of cerebral vessels does not have a similar size limitation.  Growth of
animals during follow-up has been a limitation also in other studies.  For example, the
use of DSA imaging of swine jugular vein graft aneurysms was totally hindered at 6
months because of poor radiographic quality due to growth of facial bones
(Murayama et al. 2003b).
6.5  Optimized TOF-MRA sequence
Our optimized high-resolution TOF-MRA sequence allows accurate
detection of morphological changes in neck remnant shape, such as harmful
recanalization or beneficial induced occlusion.  We performed optimization in a
simulation-based manner.   The good correlation between the theoretically calculated
and the actual acquired contrast increases the validity of our findings.
In TOF-MRA, the image is created by saturating stagnant (background)
tissue and collecting the signal from moving, unsaturated tissue (blood) that later
arrives into the imaging volume (Dumoulin 1989).  In this way, the image can be
elegantly acquired even without the use of any contrast agent.  The intensity of the
intraluminal signal from the newly arrived fresh blood (flow-related enhancement) is
dependent on the distance from the entry surface.  Therefore, the aneurysm needs to
64
be positioned at a predetermined site in the imaging volume; if the distance to the
entry surface increases, the flow-related enhancement and signal from the aneurysm
decrease.
MRA is limited by factors affecting the saturation and relaxation of protons.
3D TOF-MRA is especially susceptible to spin-dephasing caused by turbulent flow, a
problem relevant in such an environment as an aneurysm (Wilcock et al. 1995).
Signal loss may also occur when the flow is slow, because of phase dispersion.  We
overcame these problems by using a short TE and a high resolution.  With short echo
times, the signal from the flowing blood is maximized.  Longer TE would reduce the
signal-to-noise ratio, yielding images with a grainy appearance.  This is in
concordance with earlier studies (Gonner et al. 1998, Krings et al. 2002, Yamada et
al. 2004). TR 60 ms was used instead of 30 ms because short TR increased the risk
for overheating of the MR scanner, resulting in a need to abort the acquisition.  The
interpretability of images with TR 60 ms was equal to that with TR 30 ms, although
CNR was slightly lower.
A possible pitfall of TOF-MRA is that an acute or subacute thrombus containing
methemoglobine can give rise to a hyperintense signal, thereby mimicing flow
(Derdeyn et al. 1997, Moody et al. 1998, Yamada et al. 2004).  We observed no
false-positive flow signals in TOF-MRA; this result was confirmed by performing T2-
weighted RARE imaging at every imaging session.  At the end, the possibility of
thrombosis was further ruled out  by endoscopic inspection and histological analysis.
TOF-MRA was used for the first time to detect native cerebral aneurysms in
humans by Sevick et al. (1990).  Later, TOF-MRA has also been utilized for the
imaging of coiled aneurysms.  The suitability of MRA (especially TOF-MRA) for the
pre- and post-procedural evaluation of coiled aneurysms has been studied earlier
(Deutschmann et al. 2007).  Using a 1.5 T, scanner Deutschmann and colleagues
observed residual necks with a 94% sensitivity in cases where the aneurysm was > 3
mm, but only in 63.6% of cases with aneurysms < 3 mm.  They did not find any
difference between TOF-MRA and CE-MRA.  Other studies have also found that the
overall sensitivity (72-97%) and specificity (91-100%) are within the same range
(Kähärä et al. 1999, Anzalone et al. 2000, Boulin et al. 2001).
Yamada et al. (2004) used TOF-MRA to evaluate residual flow in the neck
region of 39 coiled aneurysms in humans.  They found that TOF was as reliable as
DSA in detecting residual flow.  Gönner et al. (1998) used short and ultrashort TE
when imaging coiled aneurysms in humans.  They claim that MRA does not
underestimate the size of the residual neck and even small dog ears can be seen.
They predict that TOF-MRA could be more widely used in the follow-up of coiled
aneurysms.  Anzalone et.al (2000) also concluded that TOF-MRA is suitable for
follow-up of coiled aneurysms, especially in cases with good initial correlation to
DSA.
65
To our knowledge, MRA has been used in only one previous report for the
imaging of experimental aneurysms (Krings et al. 2002).  These authors imaged
elastase-induced aneurysms in rabbits with a 1.5 T scanner, but only prior to coiling.
Their resolution (703 x 703 x 500 µm) was inferior to ours and was not detailed
enough for volumetric analysis.  Moreover, they were compelled to use Gadolinium
contrast agent in order to visualize all aneurysms.  Their imaging parameters were
within the same range as ours, although the pulse angle, which we found to correlate
with the angle derived from the Earnst equation, was different.
In our study, image quality was very good even without the gratuitous step
of contrast agent injection.  Had the images not been satisfactory, intravenous
Gadolinium injection and  CE-MRA could have been used.  In clinical practice, there
seems to be an advantage in using CE-MRA to detect aneurysms and recanalization,
although some contrary studies exist (Pierot et al. 2006, Deutschmann et al. 2007),
showing that TOF-MRA and CE-MRA to be equally sensitive.
We also assessed the effect of i) fat suppression and ii) magnetization
transfer (MT) which suppresses muscle tissue, on image quality (Figure 6).  Blood
consisting mostly of water should not be affected by either of these suppressions.
Since the experimental aneurysm is closely surrounded by intraperitoneal fat tissue,
while the muscle tissue is on the posterior side at a distance of several millimeters,
needing fat suppression instead of MT seems more logical.  In practice, we were able
to produce enough contrast between the aneurysm and fat even without suppression.
Fat suppression and MT made the automatic maximum intensity projection (MIP)
reformats clearer.  However, when analyzing data, the raw images are more
important than MIP reformats.  The relevance of background suppression is greater
in a clinical setting since the aneurysm can be located in various places and it can
project to a variety of directions.  In our experimental model, the site of the aneurysm
is clearly defined and it is easy to locate it even without background suppression.
Since there was a slight signal loss from the aneurysm when using suppression, we
decided not to use it.
The resolution achieved with the multislice TOF-MRA was 117 x 117 x 117
µm.  With this resolution, it is possible to cover the aneurysm neck with an average of
21 slices from which the volume can be measured.  We measured the volume by
outlining the region of interest manually.  In theory, this could be done automatically
by having a program that recognizes the given intensities, but it would not eliminate
the need for manually outlining the border between the aorta and the aneurysm neck.
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6.6  Platinum versus PGLA-coated coils
In Study IV, we showed that aneurysms coiled with PGLA-coated coils
exhibit progressive reduction in neck remnant size in MRI and increased fibrosis in
histology, compared with platinum coils.  However, the whole neck remnant was not
abolished, but disappearance of dog ears was significantly more prominent in the
PGLA group during the 4-week-long follow-up.
PGLA-coated coils were tested only in the jugular vein graft model in swine
and the elastase-induced model in rabbits before introduction into clinical use
(Murayama et al 2003b, Ding et al. 2005).  Murayama et al. (2003b) constructed
bilateral jugular vein graft aneurysms in 26 swine, 6 of which were followed up for 6
months.  They used rather low packing densities (18.7-25.4%) and did not measure
or monitor the aneurysm neck remnant.  By using digital subtraction angiography
(DSA), they were unable to obtain follow-up images on all planned imaging
occasions.  In histological analysis, they found that the aneurysms embolized with
PGLA-coated coils showed a more extensive area of thrombus organization and
higher amounts of leukocyte infiltration at 14 days, but complete fibrosis had occurred
in both groups at 3 months.  We used an intermediate time-point of 28 days and were
also able to show that thrombus organization and inflammatory cell infiltration were
more extensive in the PGLA group.  However, we found that in neither group was the
process complete at this point.  In the swine model, using histological analysis and
2D DSA, the PGLA-coiled aneurysms were also demonstrated to possess
significantly thicker neck tissue at 14 days and at 3 months such that the necks of all
PGLA-coiled aneurysms were completely covered with a fibrous membrane
(Murayama et al. 2003b).  We considered the measurement of the neck tissue
thickness from histological sections to be unreliable, but in endoscopic analysis the
neointima covering the neck of aneurysms coiled with platinum coils was more often
translucent or incomplete.  We doubt that this transparency is explained by the
difference in color of the devices, but rather represents true thickening.  However, the
difference was statistically nonsignificant.
Ding et al. (2005) compared PGLA-coated (Matrix?, Boston Scientific,
Fremont, CA, USA) coils (n=15) with platinum coils and expandable hydrogel coils
(HydroCoils?, Microvention, Aliso Viejo, CA, USA) in elastase-induced carotid
aneurysms in rabbits (n=33).  They found similar strong inflammatory reactions
around the PGLA-coated coils at 6 and 10 weeks and observed neck tissue
deposition in all PGLA-coiled aneurysms at 2 weeks.  These findings are consistent
with what we saw at 4 weeks.  They then evaluated the angiographic outcome as
complete/near-complete/incomplete occlusion by performing DSA at the time of
sacrifice.  Incomplete initial occlusion and aneurysm recurrence were more frequent
in the PGLA group than in the other two groups.  However, in their study, the number
of PGLA-coated coils implanted was lower than that of other coil types.  Moreover,
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aneurysm neck occlusion was evaluated by a robust scale, and angiography was not
frequently repeated.
In humans, PGLA-coated coils and platinum coils have not yet been
compared in large, randomized, prospective, long-term studies.  Human studies thus
far have shown that initial angiographic results and overall treatment-related
morbidity and mortality fall within the range of results reported in platinum coil studies
(Pierot et al. 2006).  Pierot et al. (2006, 2008) achieved complete initial occlusion in
44% of the cases coiled with PGLA-coated coils alone or combined with platinum
coils.  However, they had no control group and did not assess durability.  The safety
of using PGLA-coated coils has also been good in other studies (Katz et al. 2005,
Linfante et al. 2005, Taschner et al. 2005).  Niimi et al. (2006) conducted an average
follow-up of 12 months of 47 aneurysms embolized with PGLA-coated coils and
found a recanalization rate of 57.4%, which is worse than that reported for platinum
coils.  Other studies assessing durability and recanalization have reported moderate
improvement in radiological outcome.  In their 8-month follow-up of 87 patients,
Murayama et al.(2006) noted that the aneurysms coiled with PGLA coils remained
stable or exhibited progressive occlusion in up to 80.5% of cases.  Moreover, no
recanalization appeared in aneurysms that were initially completely occluded.  Some
aneurysms with a neck remnant showed progressive occlusion, similar to our results
in rats.  In addition, Katz et al. (2005) reported rather small recanalization rates –
14.3% in aneurysms (n=77) followed for an average of 12 months – when using
predominantly PGLA-coated coils.
The variation in results may be due to varying primary occlusion rates,
which were 17.6% in the Niimi study (Niimi et al. 2006), 26.3% in the Murayama
study (Murayama et al. 2006) and 56.3% in the Katz study (Katz et al. 2005).  The
generally low occlusion rates with PGLA-coated coils are partially explained by the
additional stiffness and friction that come with the coating.  These technical
shortcomings are currently under investigation. The results may also vary because
the wall histology and cellularity of human aneurysms can differ from case to case
(Frösen et al. 2004, 2006), and some aneurysms may therefore be less suitable for
coiling.
Gonzales et al. (2005) estimated aneurysm neck tissue thickness from DSA
images.  In concordance with findings in the swine model and our rat model, the neck
tissue had increased with PGLA-coated coils.  Because of controversy regarding the
clinical results, a larger clinical trial is needed to elucidate this issue.
In Study IV, the experimental rat model was for the first time used to compare two
different coils.  Our success rate for producing standard-sized aneurysms was high
(80%), and the costs were low.  Imaging was performed repeatedly with MRI.  It
would have improved the value of this study had DSA also been performed at one
time-point.
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Our results suggest that the PGLA-coated coils have a biological effect on
the neck remnant.  Previous experimental studies have not focused on evaluating
and quantifying this phenomenon.  We performed the aneurysm coiling so that
residual filling – the dog ears – remained between the coil mass and the aneurysm
wall, and we were able to adequately evaluate their status during follow-up.  It is
generally believed that the dog ears are potential sites for further growth and
aneurysm recurrence (Raymond et al. 1997a,b).  The PGLA-coated coils significantly
stimulated the occlusion of these dog ears, whereas the total reduction in neck
remnant size was rather moderate (12.9%).  The process of neointima formation,
which occluded the dog ears, accounts for most of the quantified reduction of the
neck remnant.  Coils were not, however, able to stimulate total occlusion of the neck
remnant.
In our experimental arterial model, we were able to mimic the real-life
situation by having a neck remnant with dog ears.  By frequently performed, high-
resolution MR imaging with newly optimized 3D TOF-MRA and volumetric
measurements, we showed progressive occlusion of neck remnants and better
angiographic outcome, seen as disappearance of dog ears during follow-up in
aneurysms treated with PGLA-coated coils.  We also performed endoscopic and
histological analyses at the 28-day endpoint.
The true benefit of PGLA-coated coils in clinical practice may be to improve
the occlusion of residual filling between coils and the aneurysm wall, possibly
preventing aneurysm recurrence.  However, because of the marginal influence of the
coils on the neck remnant itself, achieving high packing densities and good primary
angiographic outcome is still necessary with these coils.  Knowledge is growing
regarding aneurysm pathobiology (Peters et al. 1999, 2001, Frösen et al. 2004,
2006b, Tulamo et al. 2006, Laaksamo et al. 2008), and ongoing technical
development of coils should emphasize the biological effects.  In the future,
biologically active, but otherwise simple coils may work in such a way that even
incompletely coiled aneurysms would progressively and completely occlude.  It
should not be necessary for the interventionist to make a perfect architectural
construction of the coil mass.  Instead, putting only a small coil loop into the
aneurysm should be sufficient to induce aneurysm occlusion.
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6.7  Future visions for endovascular treatment
The greatest challenge in aneurysm microneurosurgery has always been
the treatment of giant aneurysms, especially those in difficult locations like the basilar
artery.  The mass of a large aneurysm interferes with the surgical maneuvering and
preparation of the aneurysm neck.  Locations such as the basilar artery are very
delicate also because of the many arterial perforators going to the brainstem, the
cranial nerves passing at a close distance, and the deep and narrow surgical corridor
to the lesion.  All of these are even more relevant in acute surgery after SAH.
Endovascular coiling has become a good alternative to surgery in the treatment of
cerebral aneurysms in general, but it has not become the definite solution for the
awkward lesion like giant aneurysms or aneurysms with a very wide neck.
Still today, almost 20 years after the introduction of endovascular coiling,
incomplete angiographic occlusion of coiled aneurysms remains a problem.  There
have been attempts to overcome this problem by developing biologically active
coatings on platinum coils, e.g. PGLA.  However, for the time being, the long-term
results appear to be highly dependent on the initial angiographic result (Sluzewski et
al. 2004).  To prevent recurrence, the volume of the aneurysm needs to occluded
with as many coils as possible.  This is an unsustainable condition when treating
giant aneurysms that might contain thrombi and already by themselves might
generate a mass effect and compress cerebral structures.  When these giant
aneurysms are treated with numerous coils, the coil mass causes additional
compression, especially if re-treatment is needed.  On the other hand effective scar
formation would cause beneficial constriction of tissues.  When the coating of PGLA-
coated coils is absorbed and replaced by mature connective tissue, the total volume
of the aneurysm has been thought to decrease.  However, thus far, this has only
been demonstrated in experimental aneurysms (Murayama et al 2003b).
The trend of developing biologically inert embolization materials, such as
Onyx and HydroCoils, is irrational in the sense that the aneurysm is filled with a cast
made of foreign material, which has no biological effect and is not replaced by fibrous
tissue.  This cast holds the aneurysm walls apart, exhibits pressure on the wall itself,
and actually interferes with aneurysm healing.  Although the treatment may be
satisfactory in many cases and aneurysms might not recanalize, the rationale of the
treatment is nevertheless somewhat illogical.  The primary justification of the use of
HydroCoils was that the improved packing density would reduce recurrences (Cloft et
al. 2004).  However, the first follow-up study with these coils did not confirm this
(Cloft et al. 2007).  Hypothetically, the expanding of the coil inside the aneurysm can
be considered a dangerous event.
70
One should also focus on the significance of incomplete occlusion.
Raymond et al. (2003) debated the risks worth taking to make the angiographic
occlusion perfect since the true risk of rebleeding might be low, even with a small
remnant.  This is reinforced by the observation that despite the vast number of coiled
aneurysms worldwide, we see less cases of rebleeding after coiling in clinical
practice than we would expect.  However, systematic, population-based, long-term
follow-up studies are needed to confirm this.
The rapid and constant evolution of new endovascular devices (3D coils,
soft coils, coated coils, stents, flow diverters, liquid agents) and combined use of
techniques have lead to a point where reliable results concerning safety and efficacy
are difficult or even impossible to find.  The results from using new devices are often
reported as single-center studies, with small study populations and often without
control groups or with historic series as controls (Kang et al. 2005).  Very few studies
provide reliable long-term results of the use of one device and even fewer compare
two devices in a randomized way.  There has also been a drive to develop more
efficient techniques, but as procedures become more demanding and complex
(balloon-remodeling, stent placement), overall safety has not necessarily improved
(Raymond et al. 2003, Nelson et al. 2006).
In the future, focus will be on the biological activity of the endovascular
device.  The treatment will rely less on skilful positioning of the coil into the aneurysm
and more on the biological activity of an otherwise simple device.  The placement of
even a small device inside the aneurysm should promote gradual occlusion and
healing with good long-term results, despite an imperfect initial angiographic result.
In our experimental rat aneurysm model, we were able to deliberately perform coiling
so that there is an initial neck remnant.  An efficient endovascular device should
promote gradual occlusion of this neck.  The neck remnant also possessed additional
blood-filled cavities projecting between the coils and the aneurysm wall, namely the
“dog ears”.  A poor endovascular device permits further growth of these dog ears.
Growth of intimal hyperplasia (neointima) is the goal in the endovascular treatment of
aneurysms (Raymond et al. 1999) and this would occlude the dog ears and the neck
remnant.
We will use the rat model to test novel endovascular devices, including
coated coils and porous stents.  The detection of inflammation (macrophage
infiltration) in a vessel wall by in vivo imaging can be done by injecting USPIOs
(ultrasmall superparamagnetic particles of iron oxide).  We are currently studying the
characteristics of USPIOs and will use USPIOs to evaluate inflammation in
experimental aneurysms in order to elucidate whether this contrast agent can help to
identify rupture prone aneurysms.
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7.  Conclusions
MRI is a reliable method for the detection of experimental murine
aneurysms.  Using a 4.7 T MR scanner, we were able to scan the cerebral arteries of
mice up to the distal branches with a resolution of 73 x 73 x 94 µm.  The Col-Int?
mouse strain is, however, not suitable for studies of aneurysm formation and
pathobiology, but other stains can be examined.
The surgically created experimental aneurysm model in rats is easy to
standardize and reproduce.  Moreover, it is suitable for endovascular treatment.  The
low mortality rate makes the model affordable.  The aneurysms remain patent for up
to 2 years and sometimes even grow.
The optimized MRI protocol provides detailed and accurate follow-up images of the
experimental aneurysms.  With the high-resolution TOF-MRA sequence, it is possible
to quantify changes in neck remnant volume during follow-up.
Aneurysms coiled with PGLA-coated coils show progressive reduction in
neck remnant size in MRI and increased fibrosis in histology compared with platinum
coils.  During follow-up, disappearance of dog ears was significantly more prominent
in the PGLA group, suggesting a true biological benefit of this device.
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